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FOREWORD
This dissertation, divided into four chapters, is concerned with the 
interaction of water soluble cigarette smoke particulate phase components 
with human alpha-1-proteinase inhibitor. Chapter 1 is a comprehensive 
introduction covering material from the literature related to the studies in 
this dissertation. Chapter 2 deals with both the basic features of the 
"aqueous cigarette tar extract" and the assay of alpha* 1-proteinase 
inhibitor activity. Chapter 3 covers mechanistic studies on the nature of 
the species in aqueous cigarette tar extract that dam age alpha-1-proteinase 
inhibitor. Chapter 4 presents studies on the structural damage to alpha-1 - 
proteinase inhibitor by aqueous cigarette tar extract. Much of the material 
in this dissertation has been published or is being prepared for publication 
in the scientific literature.
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ABSTRACT
The effect, in vitro, of water soluble com ponents of the particulate 
phase of cigarette smoke on the elastase inhibitory capacity (EIC) of human 
alpha-1-proteinase inhibitor (or,PI) is studied. Basic features of aqueous 
cigarette tar extract-mediated damage to o,PI are presented, as are 
mechanistic studies addressing the identities of damaging species and the 
nature of damage to a,PI.
Aqueous cigarette tar extract (ACT) causes a slow loss of EIC, and 
retains this o,PI damaging ability for hours. The damage to  o,PI by ACT is 
dependent on its hydrogen peroxide content. Hydroxyl radicals or 
hypervalent metal species in the homogeneous phase of ACT do not 
damage ayP\, which is compatible with their high reactivity and poor 
selectivity. Hydrogen peroxide accounts for the major portion of the 
damage to ACT-exposed a,PI, probably by direct oxidation of critical 
methionyl residues. Free methionine, but not methionine sulfoxide, 
protects against damage to o,PI by ACT. Also, ACT-exposed o,PI contains 
appreciable methionine sulfoxide. The a,PI exposed to ACT also undergoes 
non-oxidative modification to produce a more anionic protein, but such 
modification does not contribute to the loss of EIC.
Hydrogen peroxide, at concentrations relevant to those produced in 
ACT, causes a comparable rate of loss of EIC and appreciable formation of
xiv
methionine sulfoxide in or, PI. However, hydrogen peroxide does not 
reproduce the non-oxidative modifications of ACT-exposed a,PI. Although 
exposures of a,PI to catechol/hydroquinone shows some similarities to 
ACT, it is generally a poorer model compared to hydrogen peroxide.
Sulfhydryls and ascorbate protect o,PI in ACT due to various factors, 
such as direct reaction with hydrogen peroxide. Chelators do not protect 
o,PI completely from ACT-mediated damage, despite many potential roles 
for metals in the damaging mechanism. The small protection that is 
afforded by the chelators is probably related only to the inhibition of 
production, or the degradation of, hydrogen peroxide.
xv
CHAPTER 1
INTRODUCTION
Inhalation of smoke from smoldering plant matter has been practiced 
for centuries. Tobacco is the plant most commonly associated with 
smoking, although a host of plant materials have been and continue to be 
smoked. During his voyages to the New World, Christopher Columbus 
observed the native Americans indulging in the modern-day habits of 
smoking and chewing tobacco. The use of tobacco became popular in 
Europe in the 16th century, aided by the promotional efforts of Sir Walter 
Raleigh. Also during this time, Seville in Spain became a center for an early 
tobacco industry, where quality cigars were produced. It w as probably in 
Seville that the name "cigarette" first originated from the use of cigar 
scraps to make a poor m an's substitute for relatively expensive cigars. 
However, the modern concept of a cigarette as tobacco rolled up in paper 
probably started in Central America, subsequently spreading to the 
Southwest United States in the early 1800s. During the 19th century the 
popularity of cigarettes grew, and the invention of the first cigarette- 
making machine in 1881 by Jam es Bonsack of Virginia meant that the 
cigarette industry could develop into the multi-million dollar industry it is 
today. The profits to be reaped from tobacco were recognized by the
1
2British Crown during the 17th and 18th centuries. The resulting erosion of 
tobacco growers ' profits in the Americas, by the declaration that tobacco 
w as a royal monopoly, undoubtedly contributed to the ultimate loss of 
Britain's American colonies in 1776. The financial benefits gained by 
industry and government from the use of tobacco, however, have been 
outweighed by the detrimental health effects suffered by many tobacco 
consumers. The harmful effects of tobacco use are the basis for the 
studies in this dissertation.
1.1 The Physical and Chemical Nature of Cigarette Smoke.
Throughout this dissertation, the terms "smoke" and "cigarette 
smoke" refer exclusively to smoke derived from burning tobacco. Cigarette 
smoke is a dynamic system composed of an electrically neutral aerosol of 
liquid particles suspended in a mixture of primarily atmospheric gases. The 
average diameter of the particles in fresh smoke is about 0 .15  - 0 .16  jjm. 
After 1 s of aging the diameter of the particles can be as large as 0 .4  ym,  
due to particle coalescence (1,2). Smoke, with its particle concentration of 
approximately 1.3 x 101o/cm3 (3), is a highly concentrated aerosol, more so 
than many other types of environmental pollutant. Since the average 
cigarette "puff volume" is 35 cm 3, a smoker inhales about 4 .6  x 1011 
particles per puff.
3h 1,1 Sidestream smoke.
Sidestream smoke is the smoke that issues from the smoldering coal 
end of the cigarette. Numerous components of mainstream smoke, many 
of which are toxic, are present at substantially greater concentrations In 
sidestream smoke (4). Thus, passive smokers also are exposed to a 
significant burden of toxicants by inhalation of environmental tobacco 
smoke (4).
f. f'2  Mainstream smoke.
Mainstream cigarette smoke exits from the butt-end of a cigarette as 
air is drawn over the firecone during puffing. The enormous complexity of 
compounds in cigarette smoke results from a combination of distillation, 
pyrolysis and combustion of tobacco material at temperatures up to 900  °C 
in an oxygen deficient, hydrogen rich atmosphere. Dube and Green (3) 
have presented data showing that there are 3800  identified compounds in 
tobacco smoke. The most studied portion of cigarette smoke (gas and 
particulate phases) comprises < 20% w /w  of the whole smoke, the rest is 
nitrogen, oxygen and carbon dioxide (3,5).
In many cases both mainstream and sidestream smoke are 
subdivided into gas and particulate phases for both chemical analyses and 
biological studies. The gas (or vapor) phase of cigarette smoke is defined 
as that portion of the cigarette smoke that passes through a glass fiber 
filter rated to remove 99 .9%  of all particles a: 0.1 /ym in diameter, i.e., a
4Cambridge filter (6). The smoke phase collected on the filter is the 
particulate phase. Also, a "semivolatile phase” has been proposed by 
Williamson e t a/. (7), which is composed of material that is volatilized at 
180-190 °C from particulate matter on a Cambridge filter.
The Cambridge filter is probably the most widely used device for 
collecting cigarette smoke components. Cambridge filters effectively 
separate the gas phase from the particulate phase components, but there 
are components common to both phases. Components of the gas phase 
that are hydrophilic can deposit on the filter as it becomes w etted with the 
collection of particulate matter (6). Generally, the collection of cigarette 
smoke on a Cambridge filter at room temperature does not result in the 
formation of artifacts (3). However, artifacts arise as a necessary 
consequence of the aging of smoke and these could be important in a 
biological context. Such artifacts have been of particular interest to the 
Pryor research group, as is evident from the results presented in this 
dissertation and earlier work (8-11).
/■ 1.3 Gas phase smoke.
Table 1 shows some of the major classes of compounds in gas 
phase cigarette smoke along with the approximate quantity of the largest 
representative. Some of the compounds which are of interest from the 
point of view of smoke toxicology are also noted.
Table 1. Major components of gas phase cigarette smoke*.
5
C lass Largest Representative, i/o/cia.
Various C compounds Carbon monoxide, 10000-23000
Various N compounds Nitric oxide, 50-600
Ammonia, 50-170
Alkanes
Alkenes
Alkynes
Aromatic Hydrocarbons
Halogenated Hydrocarbons
Alcohols
Aldehydes
Ketones
Nitriles
Nitrosamines, 0 .0005-0 .2  
Methane, 800 
Isoprene, 400  
Acetylene, 25 
Toluene, 80  
Benzene, 20-50 
Methyl chloride, 160 
Vinyl chloride, 0 .0013-0 .016  
Methanol, 180 
Acetaldehyde, 500-1200 
Acrolein, 50-100 
Formaldehyde, 50-100 
Acetone, 350
Hydrogen cyanide, 150-300 
Acetonitrile, 140
a - Data from Refs 5 and 12.
6These include ciliatoxic agents ,e.g. HCN, acrolein and acetaldehyde, and 
carcinogens, e.g. benzene, formaldehyde and vinyl chloride. 
h f ,4  Particulate Phase smoke.
There are distinctions between total particulate matter (TPM: the 
abbreviations used throughout this dissertation are listed in Appendix A), 
"tar" and condensate. The TPM is the particulate material collected on a 
Cambridge fitter using the "puff-protocot" smoking method. The puff- 
protocol is based on patterns noted for smokers and is a standard method 
of smoking cigarettes for analytical purposes. The protocol consists of 
puffs of 35 ± 0 . 5  mL drawn over a period of 2 ± 0 .2  s at intervals of 60 
± 1 s (13). "Tar" is defined by the Federal Trade Commission as the 
weight of TPM minus the weight of water and nicotine (13). Cigarette 
smoke condensate is whole smoke collected in a low temperature trap, or 
bubbled through an aqueous buffer. The term "condensate" is frequently 
used incorrectly in the literature to refer to TPM or tar.
The particulate phase is much more chemically complex than the gas 
phase. Table 2 shows a typical composition for the major groups of 
compounds in the particulate phase. The particulate phase has been 
studied closely with respect to its co-carcinogenic and carcinogenic 
properties (discussed in section 1.2).
7Table 2. Major groups of chemical compounds in the particulate phase 
of cigarette smoke".
Class Quantity, ma/cio.
Humectants 3.0
Nicotine/nornicotine 1.6
Leaf pigment 1.5
Hydrocarbons 1.5
Carboxylic acids 1.2
Waxes 1.12
Phenols 0 .6
Aldehydes 0.5
Amides 0.1
Metals 0.1
Aliphatic amines 0 .065
Polyaromatic hydrocarbons 0 .005
Naphthalenes 0 .0 0 4
Nitro compounds 0 .004
Nitrosamines 0.0001
a - Data from (5).
87 .1.5 Free radical chemistry  o f gas Phase and particulate phase cigarette 
smoke.
1.1.5.1 Gas phase smoke. Early studies of the radicals in cigarette smoke 
used electron spin resonance spectroscopy (ESRI at liquid oxygen 
temperatures (14). Spin trapping studies, indicating that alkoxyl radicals 
are a major radical species in cigarette smoke, were performed as early as 
1971 (15). The results from more thorough spin trapping studies of gas 
phase smoke radicals suggest that carbon centered radicals generated from 
tobacco combustion are the precursors for alkoxyl radicals (16-18). Also, 
the fact that the concentration of radicals increases as the smoke ages, 
and that this closely parallels the formation of nitrogen dioxide, offers an 
explanation for the apparent longevity of gas phase smoke radicals (17,18). 
It has been suggested that nitrogen dioxide formation is related to a 
steady-state production of radicals in gas phase smoke (17,18).
The free radical chemistry of gas phase smoke has been modelled 
using a mixture of NO/air/isoprene (18,19). This gas phase smoke model 
produces both the carbon and oxygen centered radicals detected in the 
studies of authentic smoke and involves two other gas phase radicals, 
namely nitric oxide and nitrogen dioxide. However, the mechanisms 
proposed for the formation of the radicals in this model do not necessarily 
exclude other mechanisms for radical production in gas phase smoke (19).
9Reactions pertinent to radical chemistry of gas phase smoke are shown in 
equations 1 to 7 (17-19).
2 NO + 0 2 ------>  2 N 03 (1)
\  /  I I
N 02 + C=C ----------- >  CLN-C-O  (2)
^  \  I I
R» + 0 2  -------- >  R02* (3)
R02» + NO ------ >  RO* + N 0 2 (4)
R02» + N 0 2 " . . .  R02-N02 (5)
R O  + NO,  >RO-NO, (6)
R* + NO, ------- >  R-NO, (7)
NO, = NO or N 02.
1.1.5.2 Particulate phase smoke. Studies in the late 1950s and early 
1960s on the so-called "cigarette tar radical" suggested that it consisted of 
an odd-etectron delocalized over a polynuclear aromatic hydrocarbon 
structure (14,20). Later, in the early 1980s, Pryor and his coworkers 
completely revised this previously unchallenged concept of the tar radical 
(17,18,21). The studies reported by Pryor's group involve a direct 
observation of the radicals by ESR and suggest that the principal "tar 
radical” consists of hydroquinone/semiquinone/quinone units held in a 
"tarry matrix" (18,21). Since cigarette smoke is rich in polyphenols it is 
reasonable that semiquinones are present, either alone or as part of a 
polymeric framework. Data from ESR and a series of chemical tests
10
revealed that the tar radical contains mainly o-semiquinone groups and 
shares similarities with melanin, another polymer rich in o-semiquinones.
The addition of base to alcoholic extracts of particulate phase smoke 
results in the appearance of strong p-benzosemiquinone radical signals 
(17). The relative abundance of hydroquinone in cigarette smoke is 
compatible with this observation.
Spin-trapping studies have been applied to aqueous buffer extracts 
of the particulate phase (22). Three spin adducts resulting from hydroxyl, 
alkyl and carbon dioxide radical anions are detectable, and their formation 
is dependent on hydroxyl radical production in the extracts. The hydroxyl 
radicals are thought to arise from metal-assisted decompositions of 
hydrogen peroxide. The hydrogen peroxide in turn is generated by 
autoxidation of polyphenols in the extracts (22-25). Thus, the 
abundant polyphenols in cigarette smoke could be the ultimate source for 
all the free radical species detected in the particulate phase.
1 l2  Cigarette Smoking as a Maior Health Threat.
A number of disease s ta tes are causally related to tobacco smoking. 
The three major pathological conditions associated with smoking are 
cardiovascular disease, cancer and chronic obstructive pulmonary disease 
(26). These are probably the major causes of morbidity and mortality in 
the developed world (27). Smoking is also associated with retardation of
11
fetal growth, increased neonatal mortality, peptic ulcer disease and allergic 
immune reactions (26). Non-smokers, due to passive smoking, are also at 
risk to the possible detrimental health effects of environmental tobacco 
smoke.
Cigarette smoke is thought to contribute to cardiovascular disease by 
increasing carboxyhemoglobin levels in smokers' blood (28). Chronic 
exposure to carbon monoxide, at levels which are likely to be experienced 
by smokers, causes arterial wall injury and alterations in lipid metabolism 
leading to hypercholesterolemia (28). Chronic exposure to carbon 
monoxide also leads to myocardial degeneration due to stress placed on the 
heart as more blood is pumped to overcome oxygen deficiency (28).
Free radicals in smoke, formed either directly or through aging of 
smoke components, have been proposed to be involved in some 
cardiovascular disease events. Smoke radicals may modify low density 
lipoprotein and transform macrophages into lipid laden foam cells (29).
Also, smoke components can alter the plasma antioxidant s ta tus  to 
increase lipid peroxidation which could then become an important risk 
factor in the initial events of atherosclerotic plaque formation (30).
The relationship between tobacco smoking and cancer has been 
appreciated for at least 40  years. The development of lung cancer is 
known to be causally related to cigarette smoking; an increased incidence 
of lung tumors correlates with smoke dosage (31). The advent of "lower
12
ta r” cigarettes has reduced the incidence of smoking-related lung cancer, 
however, the frequency of lung cancer among smokers is still greater than 
that observed for non-smokers (31). Cigarette smoking is also causally 
related to oral cancer, cancer of the larynx, esophagus, bladder, kidney and 
pancreas (31).
The carcinogenic activity of cigarette smoke resides primarily in the 
particulate phase. Most of the compounds involved in the induction and 
maintenance of malignancy are contained in the neutral portion of 
particulate phase material fractionated by a series of extractions using 
acidic, neutral or basic solvents (12). The potent carcinogenic fractions 
contain mainly polynuclear aromatic hydrocarbons, which show  tumor 
initiation in skin tests  in the presence of co-carcinogenic fractions from the 
particulate phase (12). The major co-carcinogen and phenolic compound in 
cigarette smoke is catechol. Cigarette smoke also assists in the metabolic 
activation of some of these carcinogens by increasing aryl hydrocarbon 
hydroxylase activities in the lung and other tissues (32).
Cigarette smoke contains organ-specific carcinogens, such as 
primary amines (bladder carcinogens), thus explaining the ability of smoking 
to induce cancers at sites other than the lung. The involvement of active 
oxygen species in the carcinogenic/DNA damaging activity of cigarette 
smoke has been proposed on the basis of studies in vitro and in vivo 
(25,33-36).
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1.3 The Pulmonary Absorption and Deposition of Cigarette 
Smoke.
The deposition and clearance of cigarette smoke material in the lung 
is of prime importance with regard to its toxicity. Many of the volatile, 
water-soluble components of cigarette smoke (i.e. , gas phase components) 
are absorbed in the oropharyngeal region of the respiratory tract (37). 
However, this does not mean that gas phase smoke has no role in 
pulmonary injury (38,39).
Particle size is the major determinant of deposition patterns in the 
lung. Since cigarette smoke particulates are small and have low volatility 
they can penetrate deep into the pulmonary region of the respiratory tract 
(40-43). The three major mechanisms for particulate deposition, viz., 
sedimentation, diffusion and inertial impaction, operate in the pulmonary 
region. Impaction is the primary deposition mechanism in the 
nasopharyngeal and tracheobronchial region. The sites of development of 
bronchocarcinoma and smoking induced emphysema are located at 
bifurcations of the terminal bronchioles (44-46), which are also the primary 
sites for the deposition of cigarette smoke particulates (44-46).
Different mechanisms for the clearance of foreign material from the 
lungs operate depending on the region of the respiratory tract involved.
The particulate burden to distal parts of the lung is increased during 
cigarette smoking since the protective mechanisms in the nasopharyngeal
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region (nose hairs and impaction in nasal mucus) are bypassed. However, 
particles can impact in mucus in the oropharyngeal and tracheobronchial 
regions. The mucus lining forms part of a "mucociliary escalator", in which 
the mucus is propelled upward along with entrapped particles to the 
oropharyngeal region where the mucus is removed by expectoration and 
swallowing.
Approximately 30-40% of cigarette smoke particulate matter is 
deposited in the alveolar region where the mucociliary escalator does not 
function (40). Alveolar clearance involves dissolution of the particles and 
engulfment by alveolar macrophages (AM), which then exit the lungs via 
the mucociliary escalator. Unfortunately, particulate clearance mechanisms 
are impaired in chronic smokers, thus exacerbating the toxic effects of 
cigarette smoke (40,47).
1 A  Protein Inhibitors of Proteinases.
There are at least four ways of controlling extracellular proteolysis in 
vivo: a) regulation of proteinase synthesis; b) control of proteinase release; 
c) zymogen activation; d) inhibition by antiproteinases. Antiproteinases, a 
class of protein found in plants, animals and microorganisms, function as 
protein inhibitors of proteolysis. By presenting a scissile peptide bond in an 
idealized structural environment, an antiproteinase can prevent a proteinase 
from hydrolyzing its normal substrate. Although the exact function of
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some antiproteinases is uncertain this is not the case  for mammalian blood 
plasma antiproteinases which constitute about 10% of the total plasma 
protein (48).
L.4 , 1 Aloha-1 -proteinase inhibitor and the Semins.
There are several families of antiproteinase which are categorized 
according to the mechanistic class of proteinase they inhibit. One family of 
proteinase inhibitors is called the serpin (serine proteinase inhibitor) 
superfamily (49,50). Members of the serpin superfamily have common 
functional domains and tertiary structural features; they are single chain 
glycoproteins stabilized by internal Glu—Lys salt bridges and form 1:1 
complexes with their targets (51). One of the most familiar serpins is 
bovine pancreatic trypsin inhibitor (BPTI, Kunitz inhibitor), a favorite subject 
of protein biophysical studies.
The susceptible peptide bond directed toward the proteinase target is 
termed the "reactive site" (52). By convention, the reactive site residues 
are numbered leading away from the scissile bond so that P, and P', 
correspond to the first residues in the N- and C- terminal directions, 
respectively (53). The specificity of the inhibitor is determined by the 
nature of the P, residue, e.g. if P, is Arg or Lys, then the inhibitor is an 
antitrypsin, however if P, is Tyr or Phe, then the protein is an 
antichy motry psin.
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The kinetic parameter most commonly used to describe proteinase- 
antiproteinase interactions is the association rate constant (kMOC), which 
has values measuring less than the diffusion controlled rate. The higher 
the k_.ec for a particular proteinase the more likely that proteinase is to be a 
physiological target (54). The corresponding dissociation rate constant 
(kdi«Dc) f ° r decomposition of the proteinase-antiproteinase complex is 
usually very low (<  lO ^.s '1) for effective inhibitors. Another parameter, 
applied to the in vivo situation, is the delay time of inhibition [d(t)L i.e., the 
(>  97%) time required for a given amount of antiproteinase to completely 
inhibit an equivalent amount of proteinase (54). Calculation of d(t) is 
dependent on knowledge of the k_#oc and of the physiological concentration 
of the antiproteinase. So, for an antiproteinase to be an effective inhibitor, 
reaction with the target must be fast and essentially irreversible (54).
Alpha-1-proteinase inhibitor (o,PI), also known as alpha-1-antitrypsin, 
is the major serum antiproteinase in humans; it also acts as an 
antiproteinase in various tissues, notably in the lung (48). The 
antiproteinase function of o,PI w as first detected by its ability to inhibit 
trypsin. However, neutrophil elastase (NE) is the primary target for a,PI; 
the k_.cc value for o,PI interaction with human NE is 6.5 x 107 M ' . s '1 (55). 
Alpha,PI has been a subject of intensive investigation, partly because it is 
the major serum antiproteinase and also because the genetically determined 
deficiencies of a,PI are associated with a number of diseases.
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1.4.1.1 Alpha,PI protein structure and biosynthesis. Figure 1 is a 
schematic representation of the major structural features of a,PI. Alpha^PI 
is a single glycosylated polypeptide chain with 394 smino acids and has a 
molecular weight of 52 ± 1 kDa (51). Alpha,PI contains no intrachain 
disulfide bonds, but has a single cysteinyl residue which exists as a free 
thiol or in a disulfide linkage with cysteine or glutathione (56). The folded 
protein is globular with dimensions of 6.7 x 3.2 nm; N-linked carbohydrate 
chains are located externally at one end of the molecule with the reactive 
site at the other end (57). The carbohydrate chains have a common core 
composition, with "antennae" of identical composition attached to this core 
to give to bi- or tri-antennary structures (48,58,59). The carbohydrate 
composition of o^PI varies depending on the isoform of o,PI (51). The 
folded molecule contains 30% o-helix (9 o-helices) and 40%  /?-sheet (3 £- 
pleated sheets) (57). There are tw o intramolecular salt bridges, both of 
which stabilize the protein structure and are involved in the common 
deficiency mutations (57). The N-terminal residue is glutamate and the C- 
terminal residue is lysine (48). Alpha,PI is negatively charged at 
physiological pH (pi ca. 4.5). Also, Lys and Arg residues are concentrated 
at the reactive site end of a,PI and the acidic residues and carbohydrate 
chains at the opposite end, thus the molecule possess a notable dipole 
moment (57).
CHO Reactive Site
394
Figure 1. A schematic diagram of the major structural elements of the 
human c^PI protein, f  i , o-helix; %  ( 0-sheet; CHO, carbohydrate;
, salt bridge. (Reproduced and modified from Ref. 60 with permission of 
the American Society for Clinical Investigation).
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The reactive site sequence is shown below (61), with the susceptible 
peptide bond (Met368—Ser360) presented to the target as part of an exposed 
loop:
p* p3 P2 P, P'i P'z P'a P'*
Ala lie Pro Met360 Ser360 lie Pro Pro
This reactive site loop structure places the native a, PI molecule in a 
stressed conformation, as shown by a 6.7 nm separation between Met368 
and Ser350 in reactive site cleaved o,PI (57). The presence of a 
hydroxylated amino acid at P', in a,PI is characteristic of serpins, 
suggesting an important function (50). The P', residue is not directly 
involved in interaction of the serpin with the target proteinase 
but ensures correct folding of the antiproteinase into the conformationally 
active state (62).
There are approximately 75 known normal alleles of the a,PI gene 
(60), and within the general population there are at least twenty isoforms 
of a,PI (48). Classification of these forms is based on electrophoretic 
mobility, a system called the "Pi system". The commonest genotype of 
a,PI is PiM and so P i ^  represents the normal homozygous phenotype (48). 
In addition to the genetic diversity, the serum of a PiMM individual contains 
five isoforms of o,PI due to post-translational modifications (63). These
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five isoforms arise due to differing structural arrangements of the three 
carbohydrate side-chains and differing polypeptide chain length (63). The 
carbohydrate side-chains play no role in the proteinase inhibitory action of 
a, PI, but their removal increases the thermal lability of the protein, 
diminishes excretion of a,PI by cells and reduces the plasma half-life of the 
protein (64-66).
A lpha^l is synthesized primarily in the hepatocytes (48,63); this 
synthesis in turn regulates the serum levels of a,PI and hence of the lung 
(63). Neutrophils (PMN) and macrophages synthesize small amounts of 
a,PI (51). Despite the importance of a,PI and its substantial increase in 
concentration in the serum during systemic inflammatory responses, the 
mechanisms involved in controlling up-regulation of the a,PI gene are 
unknown (51).
1.4. 1.2 Alpha}Pi inhibitory mechanism. The generally accepted 
mechanism of action of antiproteinases is as follows:
e + i ; = = :  ei —  c ; = = ± :  ei’ -  —  e + r (8)
where, E is the proteinase target; I is the antiproteinase; C is a staole 
proteinase-antiproteinase complex and I' is the cleaved antiproteinase (52). 
In "C" the P rP ',  bond is intact, although the carbonyl group of the scissile 
peptide bond shows some tetrahedral character (52,67). This tetrahedral 
distortion is induced by interaction of the reactive site with the oxyanion 
hole and the Or of the proteinase active site seryl residue (52).
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Members of the a, PI family have an inhibitory mechanism different 
from other serpins in that the cleaved antiproteinase is unable to combine 
with the proteinase (48,68,69):
k 1 ^ 2  ^ 3  ^ 4
E + I El ^  C  ^  El*----------->  E + I* (9)
k.T k.2
The k_TCr is always less than expected for a diffusion controlled 
process, suggesting that the inhibition reaction is more complex than a 
simple bimolecular encounter (70). A proposed reaction profile for serpin- 
proteinase interaction shows docking of the two partners is a two-step 
process to give the stable El complex (C) lying in a deeper free energy 
trough compared to the corresponding proteinase-substrate complex (68). 
Consequently, the free energy of activation required for hydrolysis of the 
reactive site peptide bond is large, and thus a "good” inhibitor is not 
cleaved. The structural elements of the reactive site loop that make o,PI 
an inhibitor and not just a good substrate are still unknown. Since k , and 
k 2 in equation 9 have finite rates, OtPI is strictly a reversible inhibitor. But 
the values of k., and k 2 are so low that c^PI is usually termed a "pseudo- 
irreversible inhibitor" (68,71,72). In a physiological context the back 
reactions are of no importance since proteinase-antiproteinase complexes 
are cleared much faster from the circulation than the rate of complex 
dissociation (68).
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The complex between or1PJ and its target proteinase is stable enough 
to imply a covalent linkage between the two, although a complex 
containing an acyl-enzyme intermediate or a "relaxed” inhibitor is 
considered unlikely (68,69). Usually NE remains attached to o^PI in a 
highly stable complex (48). Cleavage of the reactive site peptide bond of 
a,PI yields a 47 .8  kDa N-terminal fragment and a 36 residue, 4 .2  kDa C- 
terminal fragment that remains tenaciously bound to the larger fragment 
under physiological conditions (48). A number of human serpins modified 
by reactive site cleavage exhibit conformational changes resulting in a large 
increase in conformational stability (73). The increased stability of o^PI 
after cleavage may be due to the completion of a 5 strand £-sheet using 
the reorganized reactive site loop in the cleaved inhibitor (57,69,74).
Smaller proteinase inhibitors, such as BPTI, can undergo reactive site 
cleavage, but this leads to a destabilization of the tertiary structure (73). 
These smaller inhibitors can also undergo reactive site peptide bond 
resynthesis by proteinases (73). A comparison of the solution structure of 
the native and cleaved forms of a,PI shows no evidence of gross "global” 
conformational changes (74). Thus, the local changes induced by cleavage 
result in relatively minor gross structural changes in the c^PI.
The cleavage of serpins is accompanied by a complete loss of 
inhibitory activity and such cleavage in vivo usually arises from abortive 
interactions with proteinases. The reactive site peptide bond in a,PI is also
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susceptible to cleavage by proteinases that are not inhibited by a,PI (48). 
This proteolytic action may be a physiological mechanism to control 
proteolytic activity by inactivating the inhibitor.
1 .4 .1 .3  The catabolism of a,Pl-proteinase complexes. Uncomplexed or,PI 
has a plasma half-life in humans of 4-5 days (60). The unglycosylated or 
asialoglycoprotein has a somewhat shorter half-life, measured in terms of a 
few hours (60,65).
Serpin-proteinase complexes are cleared from the circulation via 
receptors on hepatocytes (75,76). This clearance is independent of the 
identity of the serpin (76,77). Structural features of the serpin revealed 
due to conformational changes induced by interaction with the proteinase 
target are probably the basis for recognition of serpin-proteinase complexes 
by receptors (77,78),
The o,PI-NE complex and reactive site cleaved-t^PI are not 
biologically inert entities destined simply to be degraded. There are 
receptors for the a,PI-NE complex on AM and other cells. These receptors 
not only serve as a binding site for catabolism of the complexes but may 
also be associated with signal transduction mechanisms for increasing the 
expression of the a, PI gene (79). The cell surface receptor recognizes a 
pentapeptide sequence which is revealed when o,PI forms a complex with 
the target or when o^PI is proteolytically modified (80,81). While the
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native <7,PI inhibits PMN migration (82), or,PI-NE complexes and reactive 
site-cleaved-OfPI are chemotactic agents for PMN (83,841.
U i  Luno Proteinases. Antiproteinases and Connective Tissues.
1,5,1 Antiproteinases.
Alpha,PI is present at simitar concentrations in epithelial lining fluid 
(ELF) throughout the lung, and constitutes > 90% of the anti-NE activity in 
the ELF of the lower respiratory tract (51,85,861. The highest 
concentration of a,PI is detected in the blood plasma. The concentrations 
in the alveolar interstitial spaces and alveolar ELF are about 50-70%  and 
10%, respectively, of the plasma concentration (51). Although a,PI 
represents the major lung antiproteinase, there are other antiproteinases 
present. Table 3 provides details of the major antiproteinases relevant to 
the lung.
1,5-2 Proteinases.
Neutrophils and AM are the major sources of lung extracellular 
proteinases. These proteinases are generally of the serine- and 
metalloproteinase mechanistic class (87). The PMN are undoubtedly the 
major source of lung extracellular proteinases, capable of releasing NE, 
cathepsin G, collagenase and gelatinase (87-91). All of the PMN 
proteinases are stored in an inactive form in three types of granule within 
the PMN cytoplasm (87). Release of the proteinases into the extracellular
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Table 3. Major antiproteinases relevant to the lung*.
Antiproteinase MW Proteinase Plasma ELFfc conc.
(kDa) Target conc. (/sM) {//M}
C r , P I
SLPI
o^AChy
TIMP
52 NE, Cathepsin G 2 0 - 5 3
12 NE, Cathepsin G 0.004-
0 .007
68 Cathepsin G
29 Coliagenases
Stromelysins
720 All classes of
6  -  8
0 .03
2.5 - 5.0
2 -  6
1.0  -  1.2
0.5  - 1.0
?
0.01
proteinase
a - Reproduced and modified with permission from Ref. 51. 
b - Abbreviations: o^AChy, alpha-1 -antichymotrypsin; o3M, alpha-2- 
macroglobulin; ELF, epithelial lining fluid; NE, neutrophil elastase; SLPI, 
secretory leukoproteinase inhibitor; TIMP, tissue inhibitor of 
metalloproteinases.
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medium takes place by three main modes: a) leakage from phagocytic 
vacuoles during particle engulfment; b) degranulation in response to an 
inflammatory stimulus, and c) cell death (87).
Neutrophil elastase is the most important proteinase both with 
regard to c^PI and the destruction of the lung connective tissue matrix 
during pathological conditions (87). However, NE is essential for the 
antimicrobial function of PMN. The NE content of human PMN varies 
between individuals. Individuals with genetically determined higher levels 
of NE in the PMN are at a greater risk for developing lung disorders such as 
emphysema (92,93).
Human neutrophil elastase (HNE) is a cationic, globular, 30  kDa 
glycoprotein consisting of a single polypeptide chain with 220 amino acid 
residues, four disulfide bridges and two Asn-linked carbohydrate chains 
(91,94-96). Human NE derives its name from its ability to digest elastin, 
but it will hydrolyze appropriate peptide bonds exposed on other 
extracellular proteins (87). The substrate binding pocket of HNE is 
hemispherical, relatively hydrophobic and constricted at the base by bulky 
residues (96). The binding pocket is suited to accomm odate residues with 
small aliphatic side chains: HNE preferentially hydrolyses peptide bonds 
with Val in the P, position (91). Elastin is abundant in residues such as Ala 
and Val (96). The HNE substrate binding site can also interact with, and 
hydrolyze, peptide bonds with Met in the P, position, e.g. Met368 of a,PI
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(91). However, oxidation of Met368 in o,PI to the sulfoxide results in severe 
steric hinderance to binding (96), which explains the 2000-fold decrease in 
f ° r HNE interaction with native ff,PI vs. a,PI containing methionine 
sulfoxide at position 358 (MetSO358) (55,72,91). Alpha,PI containing 
MetSO368 is much poorer at inhibiting elastolysis than is the native inhibitor 
(72). Also, the HNE-o,PI complex formed from a,PI containing MetSO358 is 
less stable than that formed from native o,PI (71,72).
The mechanism of catalysis by HNE typifies that of the serine 
proteinases with regard to the so-calted "catalytic triad" of Ser, His and 
Asp (96). The His residue acts as a proton acceptor from the nucleophilic 
Ser in the active site, and development of positive charge on His is 
stabilized by the Asp (97). The development of negative charge on the 
carbonyl oxygen of the scissile peptide bond during nucleophilic attack of 
Ser-Or is stabilized by hydrogen bonding interactions with main chain -NH 
groups in the "oxyanion hole" (97).
Alveolar macrophages are also a source of cathepsins and various 
metalloproteinases. Although elastinolytic activity in vitro has recently 
been described for AM, their role in extracellular proteolysis is poorly 
defined as compared to PMN (87,98-101).
28
1-5.3 Connective tissues.
The pulmonary interstitium is that region of lung tissue that lies 
between the lung epithelial cell layer and the endothelial cell layer of the 
capillaries. The pulmonary interstitium is composed of basement 
membranes associated with the respective epi- and endothelial cell layers 
and also various cell types and a continuous fibrous protein network. The 
structural integrity of the interstitium is provided by several connective 
tissue matrix components, the major elements being collagen, elastic fibers, 
fibronectin, proteoglycans and basement membranes. AM of the various 
connective tissue components are integrated into a large structure 
encompassing the lung. This integrated structure is dynamic since many of 
the components are continually synthesized and degraded.
1.5.3.1 Eiastic fibers. [The information concerning elastic fibers is derived 
from Ref. 102]. Elastic fibers are present in most organs of the body, 
where reversible extensibility or deformability are required, particularly the 
lungs and arteries. These fibers are composed of two structural elements; 
elastin and microfibrils. Elastin is an insoluble, hydrophobic, cross-linked 
macromolecule which forms a three-dimensional network and gives elastic 
fibers their elastic recoil properties. The microfibrils consist of highly 
glycosylated proteins. Microfibrils act as  nucleation sites for the 
development of elastic fibers; elastin synthesis is at its most intense during 
the late fetat/early postnatal stages of development, resulting in lifelong
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elastin deposition patterns that are complete by the end of the first decade 
of life. Since most of the elastic fiber framework is established early in the 
development of the lung, and because minimal elastin synthesis occurs in 
adult lung, destruction of elastic fibers is essentially an irreversible process.
Tropoelastin, the monomeric precursor of functional elastin, is 
synthesized in myofibroblasts as a 70 kDa protein which is secreted and 
readily incorporated, under cellular guidance, into growing elastic fibers. 
Tropoelastin consists of alternating hydrophobic and cross-linking domains, 
and extensive intra- and intermolecular cross-linking of tropoelastin 
molecules yields mature elastin. Cross-linking is initiated by oxidation of 
selected Lys residues to aldehydes (allysine), catalyzed by lysyl oxidase. 
Cross-links are formed in three main ways: a | aldol coupling of two 
allysines; b) Schiff's base formation between Lys and allysine followed by 
reduction to tysinorleucine; c) desmosine formation from the reaction of 
four Lys side-chains. Elastin is also rich in Gly and there is a high 
proportion of small chain aliphatic amino acids such as Ala, Val, Leu and 
lie. Whereas tropoelastin is sensitive to proteolytic degradation before 
incorporation into the elastin macromolecular structure, mature elastin is 
very stable.
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1 l£  g,PL Emphysema and Cigarette Smoking.
Emphysema is a chronic lung disease that is characterized by 
abnormal and permanent enlargement of the respiratory regions of the lung 
distal to the terminal bronchioles (46,103). This enlargement is frequently 
accompanied by connective tissue destruction (46,103). There are two 
major forms of emphysema: a) panacinar emphysema, which develops 
uniformly throughout alveoli in the distal part of the acinus; b) centriacinar 
emphysema, which is confined to the central region of the acinus (46,103). 
Centriacinar emphysema is the more commonly observed form of the 
disease, and is associated with cigarette smoking (46,104,105).
Emphysema develops as a result of excessive proteinase burden to 
the alveolar interstitium (106-109). The proteinases are derived primarily 
from PMN, although AM could also play a role (100,106). Individuals with 
an inherited deficiency of plasma o,PI are at greater risk for developing 
emphysema, thus o,PI function is suggested to be intimately associated 
with the pathogenesis of the disease (110). Also, since the function of 
o,PI is to inhibit NE, then NE is probably the major destructive proteinase in 
emphysema. Support for the involvement of proteinases in emphysema is 
provided by the detection of emphysematous lesions in the lungs of 
experimental animals after intratracheal instillation of proteinases, such as 
porcine pancreatic elastase and NE (46,106). These various observations 
are unified in a common concept known as the "proteinase-antiproteinase
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theory of emphysema", which proposes that emphysema develops as a 
result of unrestricted proteolytic activity in the lower respiratory tract 
(108,109,1111. This theory explains the pathogenesis of emphysema 
resulting from cigarette smoking or inherited deficiencies of c^PI.
1<6,1 Inherited emphysema.
In order for emphysema to develop, the levels of circulating o,PI 
need to be below a critical level (60). Normal serum o,PI concentrations 
can lie between 20 and 53 //M; concentrations below 11 /sM place an 
individual in the "at risk" category for the development of emphysema (60). 
There are two common inherited o,PI variants that can place a person at 
such a risk, these are the "Z" and "S" variants. Greater than 90%  of all 
cases of serum o,PI deficiency are due to Z homozygotes, who have serum 
a,PI concentrations in the range 3-7 //M; the SZ heterozygote is mildly at 
risk in the 8-19 //M range (60,63,107). The protein derived from the Z 
gene has a Lys substituted for Glu342, which results in the disruption of a 
salt-bridge, and consequent incorrect protein folding (60 ,63 ,112,113). 
Although the Z variant is synthesized normally, only about 15% of the 
protein is secreted into the plasma (60,114). A consequence of the poor 
secretion of the Z variant is intrahepatocyte accumulation of the incorrectly 
folded protein which can lead to liver disease in some individuals 
(60,63,112,113). The S variant has a Val substituted for Glu284, disrupting
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another salt-bridge, which leads to excessive intracellular degradation of 
newly synthesized c^PI (60,63,113).
For the Z homozygote, emphysema manifests itself as a slow onset 
of dyspnea appearing noticeably between ages 50-60; death due to 
respiratory failure usually occurs by age 60-70 years (60,113,114). In the 
case  of Z homozygotes who smoke, the disease progression is usually 
shifted 15-20 years earlier (60,114). However, there are many instances 
of asymptomatic individuals with inherited or acquired or,PI deficiencies 
(60,108).
A variety of therapeutic strategies have been, and are being, 
developed to enhance antiproteinase activity in the lower respiratory tract 
of persons at risk for the development of emphysema (60). The more 
successful approaches have involved administration of a,PI directly to the 
lung in aerosol form (60). Also, a promising recent advance is the 
introduction and expression of the o,PI gene in the lung epithelium of rats 
(115).
1* 6 .2  Smokina-induced em physem a .
Emphysema is predominantly a smoking related disease, which 
would be eliminated as a major public health problem if cigarette smoking 
was abandoned (46,105). A variety of factors are proposed to be involved 
in the pathogenesis of smoking-induced emphysema, including decreased 
antiproteinase activity in the lower respiratory tract of smokers (116).
33
Oxidative damage to a, PI has received the most attention as the cause for 
the depletion of antiproteinase activity in smokers' lungs 
(45 ,109,116,117), however, evidence that oxidative damage to c^PI 
occurs in vivo is sparse (118,119). Cigarette smoke and inflammatory cells 
are the two main sources of oxidants that could damage o^PI.
in vitro studies using r^PI exposed to "clean" oxidation systems, 
such as  N-chlorosuccinimide, chloramine-T or myeloperoxidase/CI7H20 3 
have shown that two methionyl residues (Met368 and Met361) are oxidized to 
the sulfoxides (120,121). Also, in vitro studies using activated PMN and 
AM have shown that reactive oxygen species derived from these  celt types 
can damage c^PI and the damage is dependent on myeloperoxidase (MPO) 
activity in the case of PMN (122-126). in vivo studies have demonstrated 
that MPO can decrease antielastase activity in lung lining fluid (127), and 
MPO activity is higher in PMN from smokers' as compared to nonsmokers' 
lungs (128).
Several studies using human plasma, lung fluid and purified a,PI 
exposed to cigarette smoke have demonstrated damage to a , PI (129-136). 
In some of these reports, the damage w as presumed to be oxidative, 
perhaps involving free radical species (129 ,133 ,135 ,137 ,138), although, 
non-oxidative damage to o,PI by cigarette smoke is also probable 
(131,138). The relative importance in vivo of oxidative damage to o,PI by 
cellular vs. cigarette smoke-derived oxidants is unknown at present.
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Methionine sulfoxide (MetSO) has been detected in cr,PI recovered 
from healthy smokers' lung fluids, with no significant changes in other 
amino acids (119). The a,PI from smokers' lungs contained 4  MetSO/o,PI, 
and there were no changes in the molecular weight or electrophoretic 
mobility of the protein (119). In a different study, a*PI from healthy 
smokers' lung fluids was found to be present in the native molecular 
weight form (139). The a,PI had both normal and more cationic 
electrophoretic mobility and no t^PI with reversible oxidative modification 
was detectable (139). In contrast, 0 |PI from the lung fluids of smokers 
with emphysema has molecular weights suggestive of native, proteolyzed 
and complexed forms of the inhibitor and these studies also implied 
oxidized or,PI could be present (140).
The importance of oxidative damage to methionyl residues, 
particularly Met358, as a primary mechanism for loss of a,PI activity is 
illustrated by two sets of data. Firstly, a Val358 a,PI mutant exposed to N- 
chlorosuccinimide, MPO, activated PMN and gas phase cigarette smoke is 
resistant to loss of activity over relatively short exposure times (138). 
Secondly, otPI exposed to "clean" oxidant systems such as hydrogen 
peroxide, chloramine T or the MPO system can be reactivated by t reatment 
with MetSO-containing peptide reductase (141,142). Methionine 
sulfoxide-containing peptide reductase is a ubiquitous enzyme which 
reduces peptide bound MetSO to Met using dithiothreitol or
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thioredoxin/thioredoxin reductase/NADPH (143). However, MetSO- 
containing peptide reductase only partially reactivates a, PI exposed to 
cigarette smoke in vitro, or o,PI recovered from smokers' lungs (139,142). 
It has been proposed that MetSO-containing-peptide reductase may be a 
repair enzyme for MetSO366^ , ? !  in vivo, but this is questionable (142,144). 
Unlike o,PI, HNE is less sensitive to oxidants such as chloramine-T, cell- 
derived oxidants and smoke (124,145,146), such that antiproteinase 
activity is expected to be decreased the most by oxidative/smoke 
exposures in vivo (45).
Besides oxidative damage, proteolytic inactivation of a,PI by 
proteinases released from inflammatory cells could also play a role in 
localized deficiencies in a-,PI activity (89,147-149). Metalloproteinases 
released from PMN and AM, such as collagenase and gelatinase, are the 
prime candidates for proteinases that could inactivate cr,PI (89,147-151). 
Both oxidative and proteolytic damage to or, PI may play a role in the 
localized depression of a,PI activity in lung connective tissue disorders such 
as smoking induced emphysema, but the relative importance of each 
mechanism is unknown.
There are significantly increased numbers of AM and PMN in 
smokers' lungs (111,152-156). Also, the increased PMN population in 
smokers' lungs shows a longer residence time in the lung vasculature 
(155,157). These observations have important implications for the
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proteinase-antiproteinase theory, since PMN and AM are vectors for 
proteinases and oxidants (109,111). Both the AM and PMN are likely to 
have higher phagocytic activity, with consequent proteinase release and 
generation of reactive oxygen species, due to the increased burden of 
particulates in the lungs of smokers. The AM recovered from smokers' 
lungs are metabolically activated to produce greater am ounts of oxidants 
compared to those from nonsmokers' lungs (158-161). At least for PMN, 
cellularly produced oxidants do not directly influence elastin degradation; 
the proteinases are the primary degradative agents (162).
Various, equally valid, mechanisms have been proposed for the 
increased content of PMN in smokers' lungs. Cigarette smoke stimulates 
AM to secrete PMN chemotaxins, such as leukotriene B4 and interleukin-8 
(163). Additionally, complement component C3 is modified by cigarette 
smoke in vitro: studies in vivo indicate that the alternative complement 
pathway is activated in the lung after smoke exposure, liberating the C5a 
fragment of complement component C5, which is highly chemotactic for 
PMN (164-167). Additionally, some cigarette smoke components are 
chemoattractants, as are some degradation products of elastin and collagen 
(109,111).
Although most studies of smoking induced emphysema have 
concentrated on factors related to elastin degradation, it is also probable 
that smoking could hinder repair of damaged elastic fibers (109,116). in
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vitro studies have shown that aqueous solutions of gas phase smoke inhibit 
elastin cross-linking reactions by a substrate directed mechanism (168). 
Also, it has been demonstrated in vivo that activities of lysyl oxidase 
increase after elastase-induced tissue injury (169), but in conjunction with 
cigarette smoke such increases have not been observed (170). Thus, 
cigarette smoke generally exacerbates the effects of elastase-induced 
emphysema in experimental animals (171).
The validity of the proteinase-antiproteinase theory in vivo depends 
on the detection of decreased antielastase activity and/or increased 
elastinolytic activity in the lungs of smokers. Numerous studies over the 
years have been directed at this question and the results have aroused 
much controversy (108,109,111). Some investigators find the activity of 
a,PI in the lung fluid of smokers compared to nonsmokers significantly 
decreases (119,172), does not change (140,173-176), or increases (139). 
In cases where o,PI activity does not change it has often been suggested 
that increases in elastase activity are more important than decreases in the 
activity of antielastases (175,176). The reasons for such variations in the 
data can be attributed to differences in methodology and subject selection 
between research groups (139,177,178). Three recent studies 
demonstrate decreased antiproteinase (177,179) or o,PI (178) activity in 
smokers' lung lavage, supporting the proteinase-antiproteinase theory and 
the role of oxidative processes in emphysema (177,178). Some
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investigators have demonstrated an increase in the activity of or, PI in 
smokers' as compared to nonsmokers' plasma, which probably results from 
an inflammatory response due to chronic smoke inhalation (180,181).
Other studies on the elastolytic activity of lung fluids dem onstrate that 
activity is increased in smokers' lung fluid, mainly as a result of chronic 
exposure to smoke (176,182,183). Also, NE has been detected in close 
association with elastic fibers in emphysematous lung tissues (184). Since 
PMN from smokers' lungs display no increased propensity to release NE 
upon stimulation, the observed increases in elastolytic activity in smokers' 
lung fluid arise from the simple increase in the number of PMN (185).
The issue of decreased o,PI activity in smokers' lungs is debatable, 
and the controversy is difficult to solve with available lung lavage 
procedures. The lavage methods currently used result in mixing of protein 
populations from different lung microenvironments. Also, the sampling of 
lung ELF is probably a poor measure of o,PI and/or elastolytic activity in the 
lung compartment of primary interest to emphysema, i.e. the interstitium.
This dissertation is concerned with the in vitro interaction of water 
soluble components of cigarette smoke particulate phase with a,PI. The 
studies are aimed at examining some basic features of the damaging 
system and formulating a mechanism for the damage to o,PI. Prior to 
these studies, there have been several reports in the literature dealing with 
this aspect of cigarette smoke research. Pryor et al. have studied the
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interaction action of gas phase and sidestream cigarette smoke with a, PI in 
aqueous buffer (129,130,186-188). Additionally, several studies have 
dealt with the effects of whole cigarette smoke, prepared in aqueous 
buffers (133,135-137) or dimethyl sulfoxide (132,134), on o,PI activity. 
Particulate phase material per se  has not been studied in any depth, unlike 
the gas phase. Some of the earlier studies implied that damage to o,PI was 
oxidative, but no direct evidence for this has been presented.
The studies in this dissertation complement some of the studies 
previously presented by Pryor e t a/, concerning the effects of gas phase 
cigarette smoke on or,PI and particulate phase com ponents on DNA 
(33,34,129,130). It is hoped that the results presented in this dissertation 
will support some, and modify other, existing ideas concerning the effects 
of cigarette smoke components on biomolecules, particularly <7, PI. Some 
speculations about the in vivo situation can be made from the data, 
although further experimentation is necessary to determine the relative 
importance of cigarette smoke vs. cellularly derived species as effective 
o,PI damaging agents.
CHAPTER 2
BASIC FEATURES OF THE AQUEOUS CIGARETTE TAR EXTRACT SYSTEM 
AND THE DETERMINATION OF a,PI ACTIVITY.
2A. Basic Features of the Aqueous Cigarette Tar Extract System.
Many of the studies of cigarette smoke damage to a, PI in vitro have 
been done using organic solvent extracts of whole smoke or cigarette 
smoke condensate. Whereas tar is essentially composed of particulate 
phase components, the condensate contains both particulate and gas 
phase components. Components of the TPM that are extractable by an 
aqueous buffer are studied in this dissertation and this is not the same as 
whole smoke bubbled through an aqueous buffer. The fractionation of 
cigarette smoke into gas and particulate phases is probably the crudest 
fractionation procedure, and has been used traditionally to simplify the 
examination of the chemistry and biological effects of smoke. This type of 
fractionation necessarily neglects effects arising from interaction between 
components of the two phases. Obviously, from a biological perspective, 
an aqueous extraction is more realistic than an organic solvent extraction. 
The water extractable gas phase and particulate phase components have 
differing chemistries and probably damage a,PI by different mechanisms, as 
will be evident from some of the data presented in this dissertation.
4 0
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2. U 1 Experimental.
2 .1.1.1 Preparation o f ACT. Research cigarettes were purchased from the 
University of Kentucky Tobacco and Health Research Institute. The 
cigarettes were stored at -10 °C and before use they were conditioned over 
saturated aqueous ammonium nitrate at - 2 2  °C ( - 6 0 %  relative humidity) 
for at least 24 h (A. Vaught, University of Kentucky Tobacco & Health 
Research Institute, personal communication, 1982). The 1R1 reference 
research cigarette w as used for most of the studies. The 2R1F cigarette, a 
filter-tipped version of the 2R1 (a reference cigarette equivalent to the 1R1, 
but manufactured in 1974 rather than 1969) was also used. Some 
characteristics of the 1R1 and 2R1F cigarettes are shown in Table 4.
Cigarette smoke particulate matter was collected on a Cambridge 
filter (No. CM-113; Cambridge Filter Corp., Syracuse, NY) from two 1R1 
cigarettes, smoked down to a 23 mm butt length. Smoking w as done 
using the "puff protocol" (13), Smoke was drawn by hand through the 
Cambridge filter supported in a holder into a 50 mL glass syringe connected 
to a three-way stopcock. Gas phase smoke was expelled to the air. The 
Cambridge filter with adsorbed particulate matter w as extracted 
for 30 min at 37 °C with 5 mL of incubation buffer. The extract was then 
filtered to remove fibers coming from Cambridge filter, yielding undiluted 
ACT. The ACT from filter tipped cigarettes was prepared in the same 
manner, except the filter tipped cigarettes were smoked to down to 3 mm
4 2
Table 4. Characteristics of research cigarettes used In this study".
Cigarette TPM FTCb Tar Nicotine
mg/cig. mg/cig. mg/cig.
1R1 35.4 30.1 1.48
2R1F 28.6 23 .4 1.74
a - Source, Ref 189. 
b - Federal Trade Commission.
4 3
from the filter overwrap. The term "incubation buffer" is used throughout 
the tex t to refer to Chelex*-100-treated 0.1 M sodium phosphate, pH 7.4. 
Chelex*-100 chelating resin (200-400 mesh, sodium form; Bio-Rad 
Laboratories, Richmond, CA) was routinely used to deplete 0.1 M 
phosphate, pH 7.4 of redox active transition metal ions. The buffer was 
continuously stirred with Chelex*-100 (2.5 g resin/L buffer) for at least 12 
h. Adjustment of pH w as made when necessary, and stirring continued for 
at least 3 h after each adjustment. Chelex*-100 w as removed by vacuum 
filtration, and the pH was always rechecked.
2. 1. 1.2 The estimation of water soluble particulate m atter in ACT. Pre­
weighed vials were filled with 1 mL of either undiluted ACT or a control 
solution consisting of an extract from a Cambridge filter not exposed to 
smoke. The solutions were lyophilized to remove volatile ACT 
components. It w as assumed that volatile components were removed to 
an equal extent from all of the vials. The weight of the residue from a non­
smoke-exposed Cambridge filter was subtracted from the weight of the 
residue from the ACT. The material balance was termed 'non-volatile ACT 
com ponents'.
2 . 1. 1.3 The standard protocol for incubation of a fPf with ACT. The ACT 
prepared as above was, in most cases, diluted by half in the incubations 
with a,PI. This "half-diluted ACT" is referred to in the text as simply 
"ACT". In a few cases, however, where it is felt more appropriate, the
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extent of dilution is specified as "% v/v ACT" (referring to the percentage 
of ACT, original 5 mL solution, diluted in incubation buffer). Since the 
actual weight of material in ACT was difficult to assess  accurately, % v/v 
was considered the most suitable way to express the concentration.
The text that follows details the typical incubation conditions, but 
variations to the protocol are described at the appropriate places in the 
text. Alpha,PI used in these studies was from human serum or plasma 
(purity > 9 5 %  by SDS-PAGE; Calbiochem Corp., San Diego, CA). Stock 
solutions of 250 pg/mL a,PI in incubation buffer were routinely used. The 
stock solution of o,PI was mixed with ACT (1:1, v/v) to give the standard 
incubation concentrations. The total volume of the incubation w as 300  pL. 
The incubations were performed in the dark, in 500 pL Eppendorf vials, at 
37 °C for 24 h prior to determining elastase inhibitory capacity (EIC) (see 
section 2.2).
2 .1 .1 .4  Time course for EIC loss of a,PI exposed to ACT and gas phase  
smoke. The control for this experiment consisted of 125 */g/mL o,PI 
incubated in buffer alone. As a further control experiment, 125 pglmL o,PI 
was incubated with an aqueous extract of a Cambridge filter. Cambridge 
filter either exposed or not exposed to 20 puffs of ambient air 
was extracted as described for a cigarette smoke exposed filter (section 
2 . 1 . 1 . 1 ).
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The gas phase extracts (GPE) were prepared by bubbling smoke 
from two 1R1 cigarettes, using the puff protocol, into a vial containing 
0 .75  mL of incubation buffer maintained a t 37 °C. Immediately after 
smoking, 0 .75  mL of a 250 //g/mL a,PI solution was added to give a final 
volume of 1.5 mL. This 1.5 mL w as incubated under standard conditions. 
Aliquots of 20 pi. were removed periodically for the EIC assay. Control 
incubations were prepared using 0 .75  mL of incubation buffer exposed to 
20 puffs of ambient air by the puff protocol. This solution w as then 
treated as  described for GPE.
Direct gas phase (DGP) exposure w as performed as follows; 1.5 mL 
of a,Pi (125 //g/mL) at 37 °C w as exposed directly to the gas phase smoke 
from two 1R1 cigarettes smoked using the puff protocol. This 1.5 mL was 
then treated in the same way as noted for GPE. The control incubation 
consisted of 1.5 mL of 125 pgfmL o,PI solution exposed directly to 20 
puffs of ambient air via the puff protocol. The ACT from filter tipped 2R1F 
research cigarettes was also tested for its otPI damaging properties using 
the incubation conditions described for the ACT from 1R1 cigarettes.
2 . 1.1.5 Dose dependency of ACT damage to a tPL For concentrations up 
to and including 50% v/v ACT a 250 pglmL a,PI stock was used, diluted 
by half with appropriate combinations of ACT and incubation buffer to 
achieve the desired ACT concentration. For concentrations of ACT above
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50%  v/v, a 926 //g/mL a,PI stock was used (40.5 pL stock in 300  //L total 
to give 125 //g/mL a,PI).
2 .1 .1 .6  The effect o f  aged ACT on its ability to damage o,PI. The effect 
of aging ACT on its ability to damage a,PI was studied in two ways.
Firstly, fresh ACT or aged ACT (aged for 12 h at 37 “C, in the dark) was 
incubated with a,PI and the EIC determined at 2 and 24 h. Secondly, the 
ability of ACT to damage successive additions of o,PI was determined as 
follows. The EIC of an incubation containing ACT and 125 //g/mL a,PI was 
determined after 24 h ("first 24 h incubation"). The control was 125 
//g/mL o,PI exposed to incubation buffer only. For the EIC assays 40  //L
(2 x 20 //L) of incubation mixture was removed from a total of 300 //L, 
leaving 260 //L of incubation mixture. To this 260 //L, 2.5 //L of incubation 
buffer and 37.5 //L of 1 mg/mL a,PI was added to replenish the ACT 
incubation with fully active o,PI (125 //g/mL) for the "second 24 h 
incubation". The EIC was assessed after 0 .75  h, to ensure 100%  OtPI 
activity had been restored, and then again after 24 h. An additional control 
for the "second 24 h incubation" consisted of a mixture of 110 //L fresh 
ACT plus 150 //L of 250  //g/mL o,PI and 40 //L of incubation buffer. This 
control accounts for the fact that the second a, PI aliquot is exposed to a 
diluted ACT compared to the first exposure.
2 .1 .1 .7  pH change o f  ACT over a 24  hour incubation period. The pH of 
4 .5  mL of freshly prepared ACT was measured initially and after incubation
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for 24  h under the standard conditions. For the sake of correct 
comparison, the buffer alone was incubated under identical conditions and 
the pH measured.
2 .1 .1 .8  Exposure to ACT of a,PI enclosed in dialysis tubing. Dialysis 
tubing (Spectra/Por 6, Wet-Form, Molecular Weight Cut-Off 1,000; 
Spectrum Medical Industries Inc., Los Angeles, CA) w as prepared as 
follows: 1) the tubing was cut into convenient lengths and washed inside 
and out with deionized water; 2) the tubing was boiled for 10 min in 500 
mL of 2% sodium bicarbonate/1 mM EDTA, and then rinsed with deionized 
water; 3) the tubing was boiled for 10 min in deionized water, cooled and 
stored in a refrigerator. The dialysis tubing was w ashed both inside and 
out with deionized water just before use. Two ACT preparations were 
pooled then diluted by half to give sufficient ACT to work with. 
Approximately 5 cm of dialysis tubing, closed at both ends with clips and 
containing 400 pL of 125 //g/mL a,PI w as immersed in 10 mL of either 
incubation buffer or ACT in 15 mL screw-cap vials. The vials were 
incubated under the standard conditions. The EIC w as determined after 
24 h.
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2 .1 .2  Results.
2 .1 .2 .1  The estimation o f  water soluble particulate matter in ACT. Using 
six ACT preparations the following data were obtained (mean ± s.d.): 
Weight of Cambridge filter extract = 16.15 ± 0 .1 1  mg
Weight of ACT -  20 .33  ± 0 .73  mg
Weight of non-volatile ACT components in 1 mL ACT
= 4 .18  ± 0 .74  mg 
Thus, the 5 mL of undiluted ACT contains approximately 21 mg of 
material. Since two 1R1 cigarettes could yield approximately 71 mg of 
TPM, then approximately 30% was extracted into the buffer as relatively 
non-volatile material. This material was diluted by half in order to add a, PI 
solution, buffer and other components of the incubation. Therefore, each 
experiment contains about 2.09 mg/ml of water soluble non-volatile 
particulate phase components. This half-dilute preparation is the standard 
ACT solution for a, PI exposure and corresponds to the concentration of 
water soluble particulate matter from one 1R1 cigarette. These data also 
illustrate that the extraction procedure is reasonably reproducible, given the 
relatively crude preparation method.
2 .1 .2 .2  Time course for EIC loss o f  a}P! exposed to ACT and gas phase  
cigarette smoke. Exposure of o,PI to ACT derived from two 1R1 cigarettes 
causes a monophasic loss of EIC that is similar in extent to that seen for 
the first 5 h of exposure to gas-phase extract (Fig 2). In ACT a loss of EIC
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of 60-80%  is observed over 24 h compared to approximately 50 and 40% 
loss of EIC for DGP and GPE exposures, respectively. Aqueous extracts of 
a Cambridge filter, whether exposed, or not, to 20 puffs of ambient air, has 
no effect on the EIC of o ^ l .  The native o,PI displayed the sam e EIC over 
the 24 h incubation period.
In certain cases the amount of EIC lost by c^PI after exposure to 
ACT is dependent on the lot number of o,PI used! This variability was not 
anticipated at the outset of these studies. The reason for this inter-lot 
variation in loss of EIC is unknown. However, the variation in loss of EIC 
after ACT exposure was relatively small. The smallest loss of EIC observed 
after 24 h incubation with ACT is that shown in Fig 2 {59 ± 6%). Other 
experiments showed greater EIC losses, e.g., a mean % EIC ± s.d. of 23 
± 7% for one particular lot-number of o,PI exposed to 42 different ACT 
preparations. Despite these relatively large variations in sensitivity to ACT, 
the 24 h incubation period was used for the majority of the studies. The 
data for the a,PI damaging activities of the ACT derived from the various 
research cigarettes are shown in Table 5.
2 .1 .2 .3  Dose dependency of ACT damage to a,Pl. The ACT causes a 
concentration-dependent loss of EIC (Fig 3).
2 .1 .2 .4  The effect of aged ACT on its ability to damage a tPl. ACT aged 
for 12 h at 37 °C shows only slightly less a,PI damaging ability compared 
to a fresh sample of ACT {Table 6). Also, ACT has the ability to damage
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Figure 2. Time courses of the loss of EIC of ff,PI: ACT (■); gas phase 
extract ( • ) ;  direct gas phase U). Data shown are the mean of three 
independent runs; error bars represent s.d. where this exceeds symbol size 
(Reproduced with permission from Ref. 190).
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Table 5. A comparison of the effects of ACT from 1R1 and 2R1F research 
cigarettes on the EIC of o ^ l .
Cigarette type % EIC“
1R1 23 ± 7k
2R1F 22 ± 3"
a - These data were obtained with the same lot number of o,PI. Data are 
means ± s.d. 
b - 42 ACT preparations, 
c - 5 ACT preparations.
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Figure 3. Dose dependence effect of ACT on the EIC of o,PI. Data are 
mean of three independent ACT preparations; error bars represent s.d., 
where this exceeds symbol size (Reproduced with permission from 
Ref. 190).
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successive additions of or, PI, causing similar losses in EIC (Fig 4). The data 
in Table 7 concerning residual PPE activities and % EIC for the controls is 
required for full interpretation of Fig 4. The data in Table 7 should be used 
as follows: "control o,PI" displays 81%  PPE inhibition, and the "ACT, 0 .75  
h" shows that after addition to ACT of the second o,Pl aliquot control 
levels of PPE inhibitory ability were restored. "Dilute ACT" is meant to be 
compared with the 48 h point on Fig 4, to determine the true difference in 
EIC loss due to any depletion of damaging species with aging of ACT. The 
data concerning the pH change of ACT incubations are presented in Table 
8, and show a consistent decrease of 0.1 pH unit over a period of 24 h.
2 .1 .2 .5  Exposure to ACT of a,PI enclosed in dialysis tubing. Under the 
conditions used for dialysis, a,PI retains its porcine pancreatic elastase 
(PPE) inhibitory activity after 24 h (Table 9). Data in Table 9 are also 
presented for a,PI incubated in buffer only ("native") or ACT under the 
standard incubation conditions.
2 .1 .3  Discussion.
In terms of the degree and rate of EIC loss, ACT resembles GPE 
more closely. However, these two methods of exposure are different in 
the amount of cigarette smoke material involved. Material from two 1R1 
cigarettes w as extracted into different volumes of buffer, 1.5 and 5 mL for 
the studies using the gas phase and ACT, respectively. ACT w as further 
diluted by 50% for incubations with a,PI, i.e. the material from two 1R1
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Table 6 The effect of aged ACT on its ability to damage human c^PP.
Exposure Incubation time (h) % EIC 
remaining*
Buffer only 2 or 24 100
Fresh ACT 2 90 ± 1
Fresh ACT 24 15 ± 2
Aged ACT* 2 96 ± 1
Aged ACT 24 26 ±  4
a - Reproduced with permission from Ref. 190. 
b - Data are means ± s.d. of three ACT preparations, 
c - Aged at 37 °C, light protected for 12 h.
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Figure 4. The effect of ACT on the activity of two successive additions of 
o,PI. Each point shown is mean of three independent ACT preparations; 
error bars represent s.d. (Reproduced with permission from Ref. 190).
Table 7 Control data for use in conjunction with Fig 4.
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Incubation % PPE inhibited* % EIC"
Dilute ACT, 24 h — 25 ± 2
ACT, 0 .75  h 86 ± 1 100
Control o,PI 81 100
a - Data are means ± s.d . of three ACT preparations.
Table 8 The pH change of ACT incubated a t 37 •c.
incubation pH at 0  h pH at 24 h
50% v/v ACT" 7.38 ± 0.03 7.26  ± 0.01
Incubation buffer1 7.41 ± 0 .00 7.39 ± 0.01
a - Data are means ± s.d. of three ACT preparations,
b * Data are means ± av.dev. of two samples.
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Table 9 The effect of ACT on or,PI enclosed in a dialysis bag with a 
molecular weight cut-off of 1,000.
Incubation % PPE inhibited % EIC
Dialysis Control 73 ± 4- 100
Dialysis ACT . . . 12 ± 1"
Native 78 ± 1h 100
ACT . . . 20 ± 8°
a - Data are means ± s.d. of three incubations or three ACT 
preparations.
b - Datum is mean ± av.dev. of two separate incubations,
c - Datum is mean ± s.d. of four ACT preparations.
58
cigarettes w as effectively diluted into 10 mL. Thus, the material from two 
1R1 cigarettes in the ACT incubations is 6 .7  times less than in the gas 
phase systems. The data in Fig 2 and the relative amounts of cigarette 
smoke material in the gas phase and ACT imply that cigarette smoke 
particulate matter releases greater amounts of damaging species and/or 
such damaging species are more potent than those derived from gas phase 
smoke.
The 1R1 cigarette and its counterpart, the 2R1, is widely considered 
the reference research cigarette for chemical and biological studies. 
However, although the 1R1 is unfiltered, the addition of a filter tip makes 
no substantial difference to the a,PI damaging properties of an ACT 
(Table 5).
The experiments concerned with the aged ACT should furnish 
some information about the stability/turnover of *7,PI damaging species.
The ACT loses little damaging capability with aging, thus indicating that 
the damaging species are relatively stable. Also, ACT can generate more 
than enough species to damage successive additions of o,PI. If damaging 
species accumulate in ACT with aging then the loss of EIC of o^PI exposed 
to aged ACT would be more rapid if the damaging reaction(s) is fast. The 
assessm ent of EIC at 2 h shows that either damaging species do not 
accumulate, or they do accumulate but the damaging reaction(s) is slow.
59
Data presented later in the dissertation (section 3.2.3.21 indicate that the 
latter conclusion is probably correct.
Since the pH of ACT does not change drastically over 24 h, pH 
change is not responsible for the EIC loss of o,PI. Alpha,PI is relatively 
resistant to pH change and loses only 35%  activity when the pH is 
decreased from 7.5 to 5.0 (191). However, below pH 5.0 the proteinase 
inhibitory activity drops precipitously (191). Some or all of the EIC loss 
suffered by o,PI exposed to ACT could be due to particulates either initially 
present or formed over time in ACT. Such particulates may adsorb o,PI, 
for example, and remove it from solution to give the appearance of EIC loss 
due to molecular damage. While other data in the dissertation support 
molecular damage as the reason for EIC loss, the data from the dialysis 
experiment imply that EIC loss is not due to particulates initially present in 
ACT. However, high molecular weight polymeric material could form from 
species entering the dialysis bag early on in the incubations. Both fresh 
and aged ACT showed no visual evidence of particulates, even though 
smoke solutions have been noted to form polymeric material upon aging 
(192).
Z2. The Assay of Elastase Inhibitory Capacity.
Porcine pancreatic elastase (PPE), rather than HNE, is used 
frequently for determining o,Pl activity. Both enzymes are inhibited by
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a, PI, but the kmw values for this interaction are different, 6.5 x 10T and 
1.0 x 10* M ’.s'1 for HNE and PPE respectively (55). The most dramatic 
change in values is noted for o,PI containing MetSO36*, where the
values are 1.0 x 10s and 0 M ' V  for HNE and PPE, respectively (55).
2 .2 .1  Experimental.
2 .2 .1 .1  A ssay  protocol. The activity of PPE (Pancreatopeptidase E, E.C. 
3 .4 .21 .36 ; 140 U/mg; Calbiochem Corp., San Diego, CA) w as measured at 
pH 8 .0  and 25 °C according to the method of Bieth et al. (193). The 
reaction mixture in a final volume of 1 mL contained 0 .2  M Tris*-HCI, pH 
8.0, 0 .14  U PPE, 2.5 //g o,PI. 1 mM N-succinyl-(L-Ala)3-p-nitroanilide 
(SANA) and 0 .8  % v/v 1-methyl-2-pyrrolidinone. The PPE was 
preincubated with native or treated ^ P l  (usually a 20 pL aliquot of 125 
PQ/mL o,PI) for 5 min at 25 °C and the reaction started by the addition of 
SANA. The increase in absorbance at 410  nm was measured against a 
reference consisting of buffer and SANA only. The initial linear rate of 
absorbance change due to uninhibited PPE w as taken as 100% PPE 
activity; the decrease in this rate due to native a, PI w as taken as 100%
EIC. The % EIC w as calculated using equations 10 to 12 (overleaf).
Control values for uninhibited PPE were determined under identical 
conditions, but with omission of a,PI from the assay mixture.
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% PPE active ■* 1OO[(AA410 min'1, D/fAA^o min'1, U)] 
% PPE inactive = 100 - % PPE active
(10)
( 1 1 )
% EIC = 100[(% PPE I. a 1PI*)/(% PPE I, o,PI)] ( 1 2 )
Where, "AA410 min'1, I" is the initial rate for PPE activity in the presence of 
OtPI; "AA410 min'1, U" is the initial rate for PPE activity in the absence of 
o,PI; "% PPE I, t^PI*" is the % PPE inactive in the presence of o,PI 
exposed to some treatment; "% PPE I, a ,P r  is the % PPE inactive in the 
presence of r^PI exposed to incubation buffer only.
2 .2 .1 .2  Effect of ACT on PPE activity and the abiiity o f  a,P! to inhibit PPE. 
Normally, 20 /yL aliquots of sample containing c^PI and 50%  v/v ACT were 
used in the EIC assay, thus ACT was present at (20 i/L/1000/yL) 1% v/v in 
the assays. To test the effect of ACT on PPE activity, the assay was 
conducted as described in section 2 .2 .1 .1 , substituting the 20 jyL aliquot of 
o,PI sample with 20 jjL of 85% v/v ACT (aged for 24 h under the standard 
conditions). In a similar experiment 2% v/v ACT w as tested for any 
effects on the ability of undamaged a,PI to inhibit PPE. The assay for this 
experiment was conducted as described in section 2 .2 .1 .1 , except that
40 /sL of 50% v/v ACT was substituted for an equivalent volume of ass ay 
buffer.
2 .2 .1 .3  Estimation of the a tPf:PPE ratio in the assay mixture and its effect 
on EIC determination. The concentration of a,PI w as determined by 
calculation as described in section 2 .2 .2 .3 . The PPE concentration was
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determined using a method described by Shotten (194). Stock solutions of 
PPE (100 |/g/mL) were prepared in 0.1 M sodium hydroxide. Dilutions of
0 .5  and 0 .75  of the stock solutions were made with 0.1 M sodium 
hydroxide, and the absorbencies measured at 280 nm against a 0.1 M 
sodium hydroxide blank.
The effect of the r^PhPPE ratio on EIC determination was examined 
by assessing the % EIC of ACT-damaged a,PI using a 10 or 20 /A. aliquot 
of a,PI sample for the EIC assay. Incubations of a,PI in buffer alone or 
with ACT were performed under the standard conditions.
2 .2 .1.4 The incubation time of PPE with a tPi. The standard EIC assay 
protocol, section 2 .2 .1 .1 , includes a 5 min co-incubation of o,PI and PPE to 
achieve inhibition before the addition of SANA. In the literature, the 
selection of this time is dependent on various factors such as the 
incubation temperature and the concentration of a,PI in the sample. 
Although this 5 min time was always used, some experiments were 
performed to assess the effects of increasing this time on the inhibition of 
PPE and the EIC values. These studies simply involved incubating native or 
ACT-exposed a,PI for differing times and determining the PPE activities.
2 .2 .2  Results and Discussion.
2 .2 .2 .1 Effect o f ACT on PPE activity and the ability o f  a tPI to inhibit PPE. 
Data from four experiments gave 102 ± 1 % PPE activity (mean ± s.d.) in 
the presence of 1.7% v/v ACT. Incubation of native o,PI with PPE and 2%
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v/v ACT had no effect on the degree of PPE inhibited. These data imply 
that the 1 % v/v ACT present in the EIC assay of ACT-exposed o,PI is 
highly unlikely to affect either PPE activity or the ability of o,PI to inhibit 
PPE.
2 .2 .2 .2  The incubation time of PPE with a,PL Since o,PI activities were 
always expressed relative to a control, i.e. as % EIC, the effects of various 
treatments on the activity of a,PI could be easily compared. The use of 
% EIC also com pensates for any inherent variations in the native {i.e. 
untreated) a,PI activity. The degree of inhibition of PPE was relatively 
consistent within a lot number of a, PI. Five different lots of ^ P l  gave the 
following means ± s.d. (sample size in parentheses) for percent PPE 
inhibited (after co-incubation of o,PI with PPE for 5 min): 74 ± 2 (n =4),
91 ± 1 (n =4), 70 ± 4  (n = 11), 81 ± 2 <n = 8) and 87 ± 4  (n = 17).
Figure 5 show s the effects of increasing the a,PI/PPE incubation time on 
the percent PPE inhibited. Doubling the o,PI/PPE incubation time from 5 to 
10 min results in an increase the % PPE inhibited. When considering the 
ACT-damaged ff,PI, an increase in the a,PI/PPE incubation time from 5 to 
10 min leads to a 5-10% increase in the calculated EIC values. These 
changes in EIC resulting from an increased a,PI/PPE incubation time are 
relatively small and the effects are not transmitted to the % protection data 
(section 3.1.1.1) such that changes in the interpretation of the results are 
necessary.
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Figure 5. The effect of variation of the cr,PI/PPE incubation time on the 
degree of inhibition of PPE. Native ^ P l  {■); ACT-exposed o,PI (•} .
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2 .2 .2 .3  Estimation of the a,Pi:PPEratio in the assay mixture and its effect 
on EiC determination. In the EIC assay, 20 pL of a 125 pgimL a,PI solution 
is added to 962 pL assay buffer and 10 pL PPE stock; 20 pL 125 pg/mL 
o,PI in 992 pL total = 2.52 ^g/mL a,Pl; MW a,PI * 52 ,000.
Therefore we have, 2 .52 pg/52 ,000  = 48 .46  pmoles o r ,PI/mL.
Thus, la,PI] in assay mixture = 48 .46  nM.
For PPE, €2e0om = 5.74 x 104 M 1 cm 1 (194)
[PPE] = (1/dilution factor }(A280/ f 2ao)
Dilution factor = 0.5 or 0.75 as appropriate.
For four measurements, 0.5 and 0.75 dilutions of two separate stocks: 
[PPE] in stock -  2.19 ± 0.19^/M 
[PPE] in assay -  2.19 x (10/992) = 22.1 nM 
Therefore a,PI:PPE ratio in assay = (48.46/22.1) = 2.2
The results of varying the volume of the a,PI sample aliquot, and 
hence the ratio of a,PI/PPE, are presented in Table 10. The data indicate 
that lowering the ratio of a,PI to PPE from approximately 2 to 1 results in a 
negligible difference in the EIC value. Finally, the reason for selecting 
20 pL samples for the EIC assay is that this sample size of native a,PI gives 
the greater inhibition of PPE when the pre-incubation time of 5 min was 
used.
6 6
Table 10. The effect of alteration in the a,PI:PPE ratio in the EIC assay 
mixture on the measurement of EIC.
Sample Assay volume, 
Ml?
% PPE
inhibitedb
% EIC
Native-OjPI 20 72 ± 2 100
ACT-OtPI* 20 31 ± 5 43 ± 6
Native-o,PI 10 40 ± 1 100
ACT a, PI 10 16 ± 4 40  ± 8
a - Volume added to assay cuvette, 
b - Data are means ± av.dev. for two ACT. 
c - o,PI exposed to ACT.
CHAPTER 3
INVESTIGATION OF THE MECHANISM OF DAMAGE TO or,PI BY AQUEOUS
CIGARETTE TAR EXTRACT.
3J_ Protection Studies.
Protection studies have been used effectively in numerous 
biochemical studies and have been applied to c^PI/cigarette smoke 
interactions (130,133,135). They are used in this dissertation in an 
attem pt to elucidate the mechanism of ACT damage to c^PI. For the 
purposes of this dissertation, modifications of o,PI structure that do not 
affect EIC are not regarded as damaging, although such modifications could 
affect other properties of the protein.
Since there is pre-existing evidence that cigarette smoke causes 
oxidative damage to biological targets this was used as a starting point for 
the studies. A variety of agents were tested in the ACT system for 
protective effects toward o,PI. In the majority of cases the experimental 
procedure w as the same, but there were some variations. Some enzymes 
were used to probe the damaging mechanism, and as such it proved 
necessary to determine the effects of ACT on the activity of these 
enzymes and their assay systems.
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3. h 1 Exeerimentaf.
3 .1 .1 .1  Standard protocol for incubation o f  a fPf with ACT p/us additives. 
The incubations contained ACT, a,PI and appropriate am ounts of additives 
to probe the mechanism of damage. The effects of the additives alone on 
c^PI were also studied using controls that contained 125 //g/mL a,PI and 
the additives in incubation buffer. Incubations aimed at determining the 
effect of ACT alone contained 125 /;g/mL o,PI in ACT plus incubation 
buffer to substitute for the additive. Unless otherwise indicated, the 
incubations were performed in closed vials, under the conditions described 
in section 2 .1 .1 .3  and the EIC was determined after 24 h.
Data derived from incubations containing additives are reported as 
percent protection. Percent protection is calculated as shown in equations 
13 and 14:
% protection = 100 - % damage (13)
% damage = 100.{[100 - %EICA]/I100 - %EICJ} (14)
Where, "%EICA" is the % EIC calculated for o,PI incubated in ACT plus an 
additive and "%EICB" is the % EIC calculated for o,PI incubated in ACT 
only.
A percent damage of 100 is defined as the effect of ACT alone on 
a, PI. For a,PI exposed to ACT in the presence of additives: 100%  damage 
implies the additive has no effect: < 100% damage implies the additive 
protects or, PI; > 100% damage implies the additive enhances ACT damage
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to a,PI. Percent protection, rather than percent damage, is used routinely 
to make the data compatible with the previous studies of Pryor et at. (130).
3 .1 .1 .2  The effects o f  free amino acids on the a,P/-damaging ability of  
ACT. The amino acids were present in the incubations at 10 mM; 
methionine and cysteine were also tested at 1 mM. Stock solutions of 
methionine and cysteine were prepared fresh before each experiment. Due 
to their poorer solubility, tryptophan and phenylalanine were added as 
solids to the incubation vials, such that addition of 300  pL of solution gave 
10 mM of each amino acid.
3 .1 .1 .3  The effects o f  reducing species and hydroxyI radical scavengers 
on the afPI-damaging ability of ACT. All stock solutions were prepared in 
incubation buffer; the thiol and ascorbate stock solutions were prepared 
fresh at the start of each experiment. Some incubations of a,PI with ACT 
and 10 mM ascorbate, reduced glutathione (GSH), cysteine, dithiothreitol 
(DTT), methionine or thiourea were performed under air-purged conditions. 
Air-purged incubations comprised a total volume of 500 gL in 2 mL glass 
vials fitted with screw-caps housing teflon septa. Capillaries cut from a 
used capillary gas-chromatography column were used to introduce 
compressed air into the vials. Each vial w as hooked-up to an air cylinder 
via a capillary inserted through the septum and each vial was also supplied 
with a short exhaust capillary. Only the headspace was continually purged, 
as purging through the solution for 24 h resulted in EIC loss of the control.
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The vials were incubated under the standard conditions and EIC was 
assessed  after 24 h.
3 .1 .1 .4  The effects of metaf ion cheiators and ferric ions on the a,Pi- 
damaging ability of ACT. The standard incubation protocol and conditions 
were followed as detailed in section 3 .1 .1 .1; after 24 h the EIC was 
determined. In most cases the stock solutions were prepared in incubation 
buffer. A few stocks were prepared differently; desferrioxamine mesylate 
(Desferaf) w as prepared in deionized water; diethylenetriamine 
pentapentaacetic acid (DTPA) w as prepared in 0 .6  M sodium hydroxide; 
ferric chloride was prepared in 0.01 M hydrochloric acid. In cases where 
DTPA and ferric ions were added, the introduction of base or acid, 
respectively, did not affect the pH of the incubation buffer.
3 .1 .1 .5  Studies using cata/ase. The activity of catalase (H20 2: H20 2 
oxidoreductase, E.C. 1.11.1.6; from bovine liver, thymol-free, 11,000 
U/mg solid, 14,100 U/mg protein; Sigma Chemical Co., St Louis, MO) was 
determined using the method described by Claiborne (195), in which the 
disappearance of absorbance at 240 nm is monitored. The concentration 
of the substrate (hydrogen peroxide) was 20 mM in incubation buffer. The 
initial hydrogen peroxide concentration was slightly different between 
experimental runs, but was always ca. 20 mM. Since the results were 
frequently expressed relative to a control, this slight variation was not a 
problem. In the assay, an aliquot (2 to 10 /sL, depending on the catalase
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concentration) of sample was added to hydrogen peroxide substrate to give 
a 1 mL assay volume. The change in absorbance at 240  nm w as followed 
for a maximum of 30 s, using a hydrogen peroxide substrate reference. 
Data are expressed as initial rates, A A ^ .s '1 and/or percentage control 
activity. The catalatic activity of each incubation w as assessed  in 
triplicate.
Several preliminary experiments were conducted to determine the 
effect of single additions of catalase on the activity of a,PI exposed to 
ACT, and the effect of ACT on these relatively low catalase 
concentrations. Aliquots (2 to 10 pL) of catalase stock solutions in 
incubation buffer were added to incubations of o,PI and ACT to achieve the 
desired concentrations of catalase. The incubations were carried out as 
outlined in section 3 .1 .1 .1 , and the incubates were assessed  for EIC or 
catalase activity. Control incubations were also prepared to determine the 
effect of catalase per se  on a,PI activity.
The activity of 5500 U/mL catalase exposed to ACT w as determined 
at selected intervals over an 8 h incubation period. Incubations consisted 
of 1 mL (containing 20 pL of a 2.75 x 10s U/mL catalase stock) in 
Eppendorf vials of 1.5 mL capacity. Control incubations contained catalase 
in incubation buffer only, while ACT incubations contained 0 .5  mL of ACT, 
20 pL of catalase and 0 .48  mL of incubation buffer. The activity of 
catalase in each sample was determined in triplicate at each time point
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using a 2 pL aliquot for the assay. A further experiment w as performed 
involving addition of catalase at 0, 4  and 12 h during the 24  h incubation 
period; a "multiple addition" protocol. The incubations were as described 
for the  previous experiment, except that at 4  and 12 h, 20 p t  of 2.75 x 
106 U/mL catalase stock was added. The catalase activity w as determined 
after 24 h incubation under the standard conditions. After the final 
addition of catalase, the incubations would contain 15,692 U/mL, if all the 
catalase remained active.
The same multiple addition protocol was applied to o,PI incubations 
with ACT. The following incubations (300 pL volume in 500//L Eppendorf 
vials) were performed: 1. OtPI control; 2. c^PI + catalase; 3. OtPI + ACT;
4. c^PI + ACT + catalase. The initial volumes for incubation J_ were 150 
pL of 250 pQ/mL o,PI stock plus 150 pL of incubation buffer, for incubation 
2, 6 pL of 2 .75 x 10* U/mL catalase stock was added in place of an 
equivalent volume of buffer. For the ACT incubations; 2  received 150 pL 
of a,PI stock, 144 pL of ACT and 6 pL of incubation buffer, 4  received 6 
p i  of catalase stock instead of buffer. At 4 and 12 h, incubations J. and 2  
received 6 p L of buffer, whereas incubations 2  and 4  received 6 pL of 
catalase stock. The EIC values were determined after 24 h incubation 
under the standard conditions.
3 .1 .1 .6  The effect o f  heat denatured catalase and BSA on the activity o f  
a,Pi exposed to ACT. Catalase was prepared as a 25 mg/mL solution in
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incubation buffer and inactivatoiJ at 100 °C for 3 - 4  min. The mixture was 
then homogenized by vortexing and brief sonication. The catalase assay 
(section 3.1.1.5) w as used to confirm that the heat-denatured catalase had 
no activity. Heat-denatured catalase was added to o,PI in incubation buffer 
only or in ACT by the multiple addition protocol (section 3.1.1.51. The 
concentration of heat-denatured catalase w as thus equivalent to that of 
active catalase (1.12 mg protein/mL). The EIC values were determined 
after incubation for 24 h under the standard conditions.
Standard incubation protocols were followed for the o,PI incubations 
with bovine serum albumin (BSA; essentially fatty acid free, 
fraction V; Sigma Chemical Co.) in buffer or ACT. The BSA stock solutions 
were prepared in incubation buffer and the concentrations in the 
incubations were either 0 .58  or 5 mg protein/mL.
3 .1 .1 ,7  Studies using superoxide dismutase. The activity of superoxide 
dismutase (SOD; superoxide: superoxide oxidoreductase, E.C. 1.15.1.1; 
from bovine erythrocytes, 3360 U/mg solid, 3360 U/mg protein; Sigma 
Chemical Co.) was determined by the method described by McCord and 
Fridovich (196). This assay is based on the inhibition, by SOD, of the 
reduction of ferricytochrome c to ferrocytochrome c by superoxide 
generated by a xanthine/xanthine oxidase system (X/XO; xanthine: oxygen 
oxidoreductase, E.C. 1.2.3.22; grade I, from buttermilk, 25 U/1.5 mL, 41 
mg protein/ml, 0 .42 U/mg protein; Sigma Chemical Co.). The reduction of
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ferricytochrome c (Type IV, from horse heart; Sigma Chemical Co.) by 
superoxide and its inhibition by SOD were monitored by observing 
ferrocytochrome c  formation at 550nm. The true change in the absorbance 
due to the xanthine dependent reaction was obtained by subtracting a non- 
xanthine dependent control rate (all components except xanthine present). 
The reference for ail runs was 20 fjM cytochrome c in assay buffer.
Since all assay stock solutions were prepared in concentrated form, 
most of the assay volume was deionized water. Both the assay buffer and 
water were purged with oxygen before use. The contents of the assay 
cuvettes were as follows;
1. Control X/XO rate in absence of SOD: a total volume of 1 mL 
contained 50 mM sodium phosphate, pH 7.6, 1 mM DTPA, 20 */M 
cytochrome c, 5 mU XO and 250 pM X.
2. The SOD assay contained ail the components noted in 1, plus 5 
fjL of SOD sample in place of an equal volume of water.
Before the addition of X the basal AA560 was monitored for 
-  120 s, then after addition of X, the AAB5C was followed for a further 
1 2 0  s, over which time the change was linear.
Studies on the effects of ACT on the SOD assay were done by 
monitoring ferrocytochrome c formation and XO activity (formation of urate 
at A29B). These studies used ACT which had been incubated under the
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standard conditions before use; 0 .5%  (10^L sample) or 0 .25%  v/v (5 pL 
sample) ACT were tested.
Preliminary studies on the effect of ACT on SOD involved incubation 
of either 200 or 546 U/mL SOD with ACT under the standard conditions 
{3.1.1.1). The SOD activity was determined periodically. An incubation of 
SOD in buffer alone was used as a control. Determination of SOD activity 
was done at 1, 4  and 8  h from the start of the incubation. The SOD 
concentrations in the assay cuvettes were 1.0 and 2 .73  U/mL for the 200 
and 546 U/mL incubations, respectively. Also, 182 U/mL of SOD and 
5500 U/mL of catalase were co-incubated in ACT for 1 h, and the SOD 
activity w as determined. These experiments involving co-incubation of 
SOD and catalase were used with appropriate controls to determine if 
hydrogen peroxide w as involved in damage to SOD caused by ACT.
A multiple addition protocol was used to test the effect of SOD on 
ACT damage to a, PI. Incubations of SOD in ACT or buffer were used in 
preliminary experiments to determine survival of SOD in ACT. Aliquots of 
5 pL of an SOD stock in incubation buffer (36960 U/mL) were added to the 
incubations at 0, 4, 8  and 12 h from the start of the incubation. Since the 
final incubation of SOD (315 //L) contained 20 pL of this stock, the 
concentration of SOD was 2347 U/mL. SOD activity was measured at 3,
7, 11 and 24 h.
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The incubations of a,PI with SOD in 500 pL Eppendorf vials were as 
follows: 1. a,PI control; 2. o,PI + SOD; 3. o,PI + ACT; 4. otPI + ACT + 
SOD. The initial volumes for incubation 1  were 150 pL of 250 /jg/mL a,PI 
stock plus 150 pi. of incubation buffer; for incubation 2, 5 pL of 36960 
U/mL SOD stock w as added in place of an equivalent volume of buffer.
For the ACT incubations; 2  received 150 pL of a,PI stock, 145 pL of ACT 
and 5 pL of incubation buffer, 4  received 5 pL of SOD stock instead of 
buffer. At 4, 8  and 12 h, incubations 1  and 2  received 5 pL of buffer, 
whereas incubations 2  and 4  received 5 pL of SOD stock. The EIC values 
were determined after 24 h incubation under the standard conditions.
3 ,1,2 Results.
3 .1 .2 .1  The effects o f free amino acids on the a ,Pi-damaging ability o f  
ACT. Only the sulfur containing amino acids show any protection of c^PI. 
While Met show s protection at 1 mM, Cys protects only at 10 mM (Table 
11). The amino acids alone, at the highest concentration used, had no 
effect on the activity of o,PI.
3 .1 .2 .2  The effects of reducing species and hydroxyl radical scavengers 
on the a,Pl-damaging ability o f ACT. Control incubations indicated that 10 
mM GSH, DTT, thiourea, 5 mM oxidized glutathione (GSSG), and 50 mM 
benzoate and mannitol per se. did not affect the EIC of or, PI. Ascorbate 
alone did affect the EIC of o,PI; at 1 and 10 mM the mean % EIC ± s.d. 
values were 80 ± 5 and 87 ± 5%, respectively, after a 24 h incubation.
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Table 11. The effects of various L~amino acids on the ability of ACT to 
dam age a^PI.
Amino Acid* % Protection*
Alanine 4 ± 6
Arginine 3 ± 4
Cysteine 70  ± 7
Cysteine, 1 mM 1 0  ± 6
Histidine 0  ± 6
Lysine 8  ± 5
Methionine 80  ± 3
Methionine, 1 mM 47 ± 3
Methionine Sulfoxide 8  ± 4
Phenylalanine 4  ± 3
Proline 7 ± 3
Serine 7 ± 3
Tryptophan 4  ± 3
a - All at 10 mM, unless indicated otherwise, 
b - Data are mean ± s.d. of three ACT preparations.
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To account for ascorbate exerting this effect in ACT exposures, the % EIC 
values for a,PI incubated with ACT and ascorbate were calculated using 
the % I values (see equations 1 0  to 1 2 , section 2 .2 . 1 . 1 ) obtained for 
incubations of a^P\ with ascorbate only. The data on the effects of 
reducing species and hydroxyl radical scavengers on the a,Pl-damaging 
ability of ACT are shown in Table 12, while Table 13 shows the effect of 
some of these species under continuously air-purged conditions.
3 .1 .2 .3  The effects o f metal ion chelators and ferric ions on the a,Pl- 
damaging ability of ACT. None of the chelators or ferric ions, a t the 
highest concentrations tested, had any effect alone on c^PI activity; the 
data are shown in Table 14.
3 .1 .2 .4  Studies using catalase. The effect of -  5 to 175 U/mL catalase 
on a,PI exposed to ACT was tested, as w as the effect of ACT on -  90 to 
1450 U/ml catalase. Usually only one run of these experiments was 
performed, and taken together the experiments show  that catalase at these 
relatively low concentrations is poor at protecting ^ P l ,  probably 
because the activity is lost during ACT exposure (Tables 15 and 16). In a 
separate study (using one ACT preparation) catalase concentrations of 
1100, 5500 and 11000 U/mL protected o,?! by 33, 33 and 55%, 
respectively. Catalase alone at these concentrations did not inhibit a,PI 
activity.
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Table 12 . The e ffe c ts  o f reducing sp ec ies  and hydroxyl radical scavengers
on ACT-mediated dam age to a,PIV
Additive % Protection*
1 mM GSH 13 ± 6
10 mM GSH 89 ± 4
5 mM GSSG 15 ± 4
1 mM DTT 3 ± 1
10 mM DTT 75 ± 2
1 mM Ascorbate 3 ± 4
10 mM Ascorbate 8 6  ± 5
1 mM Thiourea 55 ± 5
10 mM Thiourea 6 6  ± 1
50 mM Benzoate 0  ± 5
50 mM Mannitol 6  ± 5
a - Based on Table 2 in Ref. 190, with permission, 
b - Mean ± s.d. of three ACT preparations.
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Table 13. The protective action of GSH, ascorbate, cysteine, DTT, 
methionine and thiourea toward or,PI in ACT under continuously air-purged 
conditions.
Additive* % Protection11
Cys 43  ± 2
GSH 72 ± 4
Ascorbate 51 ± 7
DTT 33 ± 2
Methionine 89 ± 1
Thiourea 84  ± 2
a - 10 mM.
b - Mean ± s.d. of three ACT preparations.
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Table 14 . The e ffec ts  o f metal Ion chelators and ferric ions on the activity
of o 1PI exp osed  to ACT.
Additive % Protection*
1 0 //M DTPA 1 ± 1
10 mM DTPA 31 ± 3 b
10 f*M EDTA* 9 ± 3
10 mM EDTA 42 ± I 4
10 mM EDTA + 50 mM Benzoate 32 ± 4
10 mM EGTA 14 ± 6
500 I'M Desferal* 6  ± 4
5 mM Desferal* -7 ± 4b
10 mM Bathocuproine Disulfonate 1 1  ±  6
10 mM DDC 53 ± 2
20 mM HIMDA 2 2  ± 6
10 uM Fe3+ 2  ± 2
100 $jM Fe3+ 32 ± 2
200 //M Fe3+ 25 ± 4*
200 //M Fe3+ + 50 mM Benzoate 28 ± 4
a - Mean ± s.d. of three ACT preparations, unless otherwise indicated, 
b - Mean ± s.d. of five ACT preparations.
c - Abbreviations: EDTA, Ethylenediamine tetraacetic acid; EGTA, 
(Ethylenedioxy)diethylenenitrilo tetraacetic acid; HIMDA, 
N-(2-hydroxyethyl)iminodiacetic acid, 
d - Mean ± s.d. of eight ACT preparations, 
e - Mean ± s.d. of six ACT preparations.
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Table 15 . The e ffec t of low  concentrations of cata lase  on the activity of
o.,PI exp osed  to ACT.
[Catalase], U/mL % Protection*
5.5 2 1
1 1 . 0 27
2 2 . 0 23
44.0 24
8 8 . 0 27
176.0 29
a - One ACT preparation.
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The substrate alone displays a negligible intrinsic decrease in A240. 
Alpha,PI and ACT, either alone or in combination with ACT, have no 
catalatic activity (Table 16).
Most of the catalase activity (ca. 40% ) is lost in the first 4  h and 
only ca. 5% in the subsequent 4  h of incubation (Table 17). The 
experiment in which catalase was added to ACT using a multiple addition 
protocol showed that after 24 h, 101 ± 8 % (mean ± s.d.; three separate 
ACT preparations) of the catalase activity remained as compared to the 
control incubations.
When the multiple addition protocol w as used for or, PI protection 
studies the % protection was 82 ± 1% (mean ±  s.d.; three separate ACT 
preparations). Additions of catalase alone did not affect the EIC of a, PI.
3 . 1.2.5 The effect o f heat-denatured catalase and BSA on the activity of 
a fPl exposed to ACT. Heat-denatured catalase w as used to ensure that 
catalase protection w as due to catalytic activity rather than non-specific 
scavenging of damaging species due to the presence of protein. Also, 
general protein protective ability w as tested using BSA. Heat-denatured 
catalase and 5 mg/ml BSA protect a,PI from ACT damage to a small extent 
(Table 18). The heat-denatured catalase, and BSA (5mg/mL), per se  had 
no effect on the EIC of a,PI.
3 .1 .2 .6  Studies using superoxide dismutase. Similar to the studies with 
catalase, the effect of ACT on SOD was compared to controls. Therefore,
Table 16 . The affect o f ACT on the activity of catalase.
8 4
Incubation Initial Rate* x 10 '3
AA24Q.S
% Control 
Activity
176 U/mL Catalase (rows 1 - 3)
1 Catalase + a, PI 6.2 ± 0 .3 1 0 0
2 a, PI + ACT 0 0
3 a, PI + catalase + ACT 0.5 ± 0 .2 8
Catalase, 363 U/mL 35.0  ± 2.0 1 0 0
Catalase, 737 U/mL 70.2 ± 4 .7 1 0 0
Catalase, 1100 U/mL 90,1 ± 4 .6 1 0 0
Catalase, 1463 U/mL 101.8 ± 4.2 1 0 0
Catalase, 363 U/mL + ACT 1 . 1  ± 0 . 2 3
Catalase, 737 U/mL + ACT 2 . 6  ± 1 . 8 4
Catalase, 1100 U/mL + ACT 3.4 ± 0 .9 4
Catalase, 1463 U/mL + ACT 5.4 ± 1.6 5
a - Rates are means ± s.d. of triplicate determinations on incubations. In 
all cases the experiments were run with one ACT preparation.
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Table 17. The activity of catalase (5500 U/mL) exposed to ACT for up to 
8 hours.
Time, h % Control Activity
0.5 81
3.5 69
4.0 62 ±  V
6.5 64
8.0 56 ±  1“
a - Mean ±  av.dev. of two ACT preparations.
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Table 18 . The a ffects o f heat-denatured catalase and BSA on the activity
o f a,PI exp osed  to ACT.
Incubation % Protection
Heat-Denatured Catalase 29 ± 5*
BSA, 0 .5 8  mg/mL 9 ± 1h
BSA, 5 mg/mL 36 ± 1"
a - Mean ± s.d. for six ACT preparations, 
b - Mean ± s.d. for three ACT preparations.
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there was no need to determine absolute activity of SOD. The assay 
system  for SOD w as noticeably affected by ACT. The results concerned 
with these  effects are noted in Table 19.
The basal rate of ferricytochrome c reduction is higher in the 
presence of ACT than in its absence (Table 19). This result is consistent 
with a previously reported observation (197). Since the basal rate of 
ferricytochrome c reduction in the presence of ACT is increased, one would 
expect to see an increased rate of reduction in the presence of X/XO as 
compared to X/XO alone. However, the rate of reduction by X/XO is 
approximately 30%  lower in the presence of ACT (Table 19). In the 
presence of ACT, XO activity itself was approximately 10% lower than in 
the absence of ACT. Thus, a portion of the ACT-mediated decrease in the 
rate of ferricytochrome c  reduction may be due to inhibition of XO. The 
effect of ACT could also be explained by oxidation of ferrocytochrome c or 
scavenging of superoxide, although the latter explanation is more likely in 
view of the aforementioned results (197). Lowering the concentration of 
ACT leads to a lowered basal rate of ferricytochrome c reduction, but the 
rate is not restored to control levels, and the X/XO rate is still inhibited. A 
5 fjL SOD sample w as used in the assays (section 3.1.1 .7) so as to keep 
the ACT concentration low.
The results in Table 20 are expressed as "% Reduction". Percent 
reduction is used as a measure of the rate of cytochrome c reduction in the
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Table 19 , Studies on the e ffec ts  o f ACT on the SOD a ssa y  sy stem .
Sample
•Rate x 1 0 3, A A ^ .m in '1
Basal Enzymatic Corrected*
X/XO 4.6  ± 0.1 67 .6  ± 1.2 63 .0  ± 1 . 2
X/XO + 10//L 14.1 ± 0 .3  57.5 ± 1.1 4 3 .4  ± 1 . 1
ACT
10 /yL ACT 13.8 ± 0 .3
X/XO + 5pL 8 .4  ± 0.2 51.1 ± 0 .4  42 .7  ± 0 .4
ACT
5 /sL ACT 8.7 ± 0.2
Cytochrome c 3.8 ± 0.1
"Rate x 10 3, A A ^ .m in '1
X/XO 33.4 ± 0 .2
X/XO + 10/yL 30.3 ± 0.1
ACT
a - Cytochrome c reduction; mean ± av.dev. of two 
determinations, 
b - Corrected = enzymatic - basal.
c - Urate formation; mean ± av.dev. of two determinations.
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Table 2 0 . The e ffec t o f ACT on the activity o f SOD over 8  hours.
Incubation" % Reduction
200 U/mL SOD (rows 1 - 6 )
1 Control SOD, 1 hr 29
2 SOD + ACT, 1 hr 79
3 Control SOD, 4  h 24
4 SOD + ACT, 4 h 73
5 Control SOD, 8  h 25
6 SOD + ACT, 8  h 87
546 U/mL SOD (rows 7 - 1 2 )
7 Control SOD, 1 h 1 1
8 SOD + ACT, 1 h 54
9 Control SOD, 4  h 17
1 0 SOD + ACT, 4 h 58
1 1 Control SOD, 8  h 14
1 2 SOD + ACT, 8  h 49
a - One ACT preparation.
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presence of SOD as a percentage of the rate in the absence of SOD. The 
control ferricytochrome c reduction rate for the incubation of SOD in buffer 
only was that due to X/XO; the control rate for SOD incubated in ACT was 
that due to X/XO plus 0 .25%  v/v ACT. Presentation of the data as % 
reduction allows changes in the control SOD activity to be monitored. The 
data illustrate that SOD is sensitive to ACT. Over 8  h at 37 °C, native SOD 
activity remained stable. Instead of using "% Reduction", the % SOD 
activity is estimated using equation 15:
% SOD activity = 100.{[100 - A]/[100 - B]> (15)
Where "B" is the % reduction in the presence of native SOD and "A" is the 
% reduction in the presence of SOD treated with ACT. Approximately 
50%  of the activity of 546  U/mt SOD w as lost after 8  h of exposure to 
ACT. For both 200 and 546 U/mL SOD most of the activity loss occurred 
within 1 h ( — 60% for 200  U/mL and ~ 50%  for 546 U/mL).
The reason(s) for the loss of SOD activity in ACT is unknown. 
However, one experiment demonstrated that the loss of SOD activity was 
not dependent on hydrogen peroxide. Using two separate ACT 
preparations, incubation of 182 U/mL SOD in ACT resulted in -  60% loss 
of SOD activity compared to the control. Co-incubation of 182 U/mL of 
SOD and 5500  U/mL of catalase ACT for 1 h, resulted in the same loss of 
SOD activity as seen for ACT alone. Controls showed that: catalase did 
not have any detectable SOD activity; catalase did not interfere with the
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activity of SOD; catalase slightly decreased the ACT enhanced rate of 
ferricytochrome c reduction.
Despite the sensitivity of SOD to ACT, estimated SOD activity 
varies between -  30 and 70% over 24 h, when SOD is added to ACT 
using the multiple addition protocol (Table 21). Although these activities 
were not ideal, they were preferable to a single addition experiment. If 
superoxide plays some important role in the ACT damage to a, PI, these 
additions should have an impact on the ACT-mediated damage to a, PI. 
Addition of SOD, by the multiple addition protocol, to  incubations of a,PI 
with ACT had no effect on the loss of a,PI activity. The additions of SOD 
alone did not affect the EIC of a, PI.
3 . 1,3  Discussion.
3 .1 .3 .1  The effect o f antioxidant enzym es on the AC T m ediated damage 
to a,Pi. The activity of catalase is compromised by ACT, hence the use of 
relatively low concentrations of catalase fail to provide more than ca. 50% 
protection. The reasons for this loss of activity are unknown, and the 
mechanism could be complex, given the number of com ponents present in 
ACT. However, at least one explanation could be the continual exposure 
of catalase to ACT-derived hydrogen peroxide and reducing species 
(including superoxide). Such exposure could lead to the generation of 
catalytically inactive forms of catalase, such as compound II or III 
(198,199). Also, the low concentrations of catalase could fail to provide
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Table 21. The activity of SOD added by multiple addition to ACT.
Incubation % Reduction"
Control SOD, 3 h 18 ± 2
SOD + ACT, 3 h 75 ± 1
Control SOD, 7 h 1 0  ± 2
SOD + ACT, 7 h 58 ± 2
Control SOD, 11 h 8  ± 1
SOD + ACT, 11 h 46 ± 4
Control SOD, 24 h 3 ± 3
SOD + ACT, 24 h 36 ± 4
a - Mean ± av.dev. of two ACT preparations.
93
adequate protection because of the high Km of catalase for hydrogen 
peroxide (200). Since hydrogen peroxide is produced in relatively small 
quantities in ACT (see section 3.2), the low concentrations of catalase 
could fail to  outcompete the a, Pi-damaging reactions dependent on 
hydrogen peroxide. Maintenance of catalatic activity was achieved by 
several timed additions of catalase to incubations. As a result of the 
substantial protective effect of catalase, hydrogen peroxide appears to be 
an essential component of ACT-mediated damage to o,PI. Organic 
hydroperoxides could be responsible for some o,PI damage, since catalase 
may use alkyl and acyl hydroperoxides as substrates (200). However, the 
predominance of hydroxyl radical adducts and apparent absence of alkoxyl 
radical adducts in spin-trapping studies suggest that hydrogen peroxide is 
the major hydroperoxide in ACT (22). Hydrogen peroxide is also thought to 
be involved in damage to o,PI caused by aqueous extracts of gas phase 
cigarette smoke (130).
Particulate phase smoke is reducing relative to the gas phase, yet 
cigarette smoke can oxidize various chemical species. The oxidative ability 
of smoke is achieved primarily by the products of dioxygen reduction 
(18,201-203). The generation of hydrogen peroxide in ACT has been 
demonstrated, and probably arises mainly from superoxide formed during 
autoxidation of polyphenols (particularly hydroquinone and catechol) 
present in the extracts (22-25).
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There are a multitude of reactions that can occur involving the 
autoxidation of polyphenols and the generation of reactive oxygen species. 
Some probable reactions are illustrated in equations 16 to 24: QH2, GH‘, 
quinol; Q*"( semiquinone; Q, quinone; M, transition metal complex. Many 
of these reactions could occur within the context of a "polymeric quinone 
matrix” as has been suggested by ESR studies on cigarette tar (18,21).
QH2 y  QH~ + H* (16)
QH' + M°4 ------>  O '  + H* + M<n'1l+ (17)
M,n1,+ + 0 2 ^  ^  M"* + 0 2*' (18)
Q*- + 0 2 ^ ^ Q + 0 2*- (19)
H 0 2* + H+ + 0 2*- ------------ > H 20 2 + 0 2 (20)
M'"1,+ + H20 2   >M " + + HO* + HO* (21)
2Q*‘ + 2H* ^ >  QH2 + Q (22)
QH2 + 0 2* " ^ - T Q*~ + H20 2 (23)
Q*“ + Mn + ^ Q + (24)
The partial protection shown by heat-denatured catalase indicates 
that a portion of the protective ability of native catalase may be due to 
non-specific scavenging of damaging species. Mild protection of a, PI by 
5 mg/ml (75 j/M) BSA is consistent with scavenging of damaging species 
by proteins at sufficiently high concentration. The reasons for this 
protective action are likely to include sacrificial oxidation of susceptible 
amino acid residues, such as Cys and Met if they are accessible to oxidants
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(however, see section 3.2.3.21. The single Cys-SH group of BSA is known 
to undergo oxidation to the sutfenic acid and higher oxidation s ta tes  upon 
exposure to hydrogen peroxide (204,205). By comparison, 1 mM free Cys 
(Table 8 ) poorly protects, thus the approximately 75 y M Cys-SH in BSA is 
expected to be even less protective. However, the sterically isolated BSA 
Cys-SH is probably less prone to autoxidize and thus may provide more 
effective scavenging of oxidants compared to a similar amount of free thiol 
(section 3 .1 .3.3).
Albumin (and other proteins) in lung lining fluid could provide a 
protective function in lung ELF by competing for protein damaging species 
with more critical targets. Albumins have been proposed to serve an 
antioxidant function in serum (206,207). The antioxidant function of 
serum proteins may extend to ELF since some serum proteins are likely to 
have increased concentrations in smokers' lungs, due to cigarette smoke- 
induced increases in alveolar permeability (207-209).
Earlier studies showed that SOD could diminish hydrogen peroxide 
production in ACT (23). Some other studies concerning whole smoke 
showed that SOD had only minimal effects on the smoke dam age to o,PI 
(135). The results reported in section 3 .1 .2 .4  show that even if SOD 
decreases hydrogen peroxide levels in ACT this has no effect on ACT 
damage to o^PI as measured in these studies.
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The results in section 3 .1 .2 . 6  show  that SOD is sensitive to water 
soluble cigarette smoke components and/or species derived from them.
This sensitivity of SOD is apparently greater than that shown by either 
catalase or a, PI. Comparing the damage by ACT to the three proteins 
studied: 2 .4  //M a,PI lost ~ 80%  activity in 24  h; 2.1 j/M catalase lost ~ 
40%  activity in 4 h; 1.6 SOD lost — 60%  activity in 1 h. Although 
hydrogen peroxide has been reported to inactivate copper,zinc-SOD 
(210,211), the loss of SOD activity in ACT was apparently not related to 
hydrogen peroxide since catalase did not protect (section 3 .1 .2 .6). One 
possibility is that since a, PI exposed to cigarette smoke in vitro becomes 
more anionic [this dissertation and refs (134,212) ], the same could happen 
to SOD thus interfering with the electrostatic guidance mechanism crucial 
to the activity of SOD (213).
3 . 1.3.2 The effect  of  free amino acids on the ACT m ediated damage to 
a,Pl. The protective ability of free amino acids toward ^ P l  w as tested in 
earlier studies on gas phase smoke damage to o,PI (130). The amino acid 
protection studies could provide some information on the amino acid 
residues in a,PI that are targets of cigarette smoke damage. The effects of 
eleven L-amino acids were tested which were selected for either 
demonstrated susceptibility to oxidative attack (Pro, Met, Phe, His, Trp and 
Cys) (214,215) or involvement in the proteinase inhibitory activity of a,PI 
(Met, Ser, Arg, Lys) (51,216-218). Alanine was chosen as an unreactive
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aliphatic amino acid, to test the protective effect of the o-carboxyl and a- 
amino groups.
The results (Table 8 ) Imply that the nature of the damaging species 
in gas-phase cigarette smoke and ACT show  some differences. The 
protective action of the unprotonated amine group in gas phase smoke 
exposures of a,PI is not found for ACT (130). Amines probably protect 
a, PI exposed to gas phase smoke because modification of the e-amino 
group of Lys residues in o,PI results in loss of EIC (216,217). Direct 
exposure of o^PI to gas phase cigarette smoke results in a fast and slow 
phase of inactivation [Fig 2, and Ref. 188], amines protect equally well in 
both phases, probably by different mechanisms (130). Protection from fast 
phase EIC loss was proposed to arise by interception of peroxynitrates by 
amines (130): authentic peroxynitrates mimic the fast phase of EIC loss by 
o,PI exposed directly to cigarette smoke (219). Also, carbonyls in cigarette 
smoke may react with Lys residues to generate Schiff's bases, and 
cigarette smoke can modify protein amine groups by generating 
cyanomethyl derivatives (212,220,221). Amines may protect o,PI from 
the slow phase of EIC loss due to gas phase smoke exposure by sacrificial 
oxidation and formation of cyanomethyl derivatives. However, it is unlikely 
that amines protect in gas phase smoke exposures by scavenging hydrogen 
peroxide (see section 3.2.3 .2). A previously unconsidered mechanism for 
amine protection in the slow phase is nucleophilic attack on quinones
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generated in smoke solution (polyhydroxybenzenes are abundant in 
cigarette smoke, see Chapter 1), these quinones could modify susceptible 
amine groups in o,PI (222,223).
Methionine and methionine sulfoxide protect o,PI equally from gas 
phase cigarette smoke damage (130), but only Met protects in ACT (Table 
11). The protective action of Met suggests that oxidation of Met in a,PI 
could contribute to ACT-mediated EIC loss, which is reasonable given the 
significant loss of EIC when the reactive center Met368 of o,PI is oxidized 
(see Chapter 1). Oxidation of Met to the sulfoxide by ACT is supported by 
amino acid analyses (sections 3.2.2.1 & 4.1.2) and the fact that 10 mM 
MetSO does not protect o,PI against ACT damage (Table 11). The effect 
of Cys on ACT-mediated damage to o,PI is discussed in section 3 .1 .3 .3 .
3 .1 .3 .3  The effect  of  hydroxyl radical scavengers and reducing species on 
the ACT m ediated damage to a,Pi. The data so far suggest that hydrogen 
peroxide is an important component of the mechanism by which ACT 
damages o,PI. However, it is uncertain whether hydrogen peroxide is the 
damaging species per se, hydrogen peroxide could be involved in 
generation of the ultimate damaging agents(s). Since hydrogen peroxide 
could be a source of more reactive oxidants, such as hydroxyl radicals, the 
authentic hydroxyl radical scavengers, benzoate and mannitol, were tested 
for protective effects on ACT mediated a,PI damage. The data (Table 12) 
show no protection by hydroxyl radical scavengers, suggesting that
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hydroxyl radicals generated in ACT do not affect the EIC of a,PI. However, 
in "cleaner chemical systems" a^PI is damaged by hydroxyl radicals (224). 
Hydroxyl radicals have been detected in ACT by spin-trapping studies (22) 
and have been proposed to contribute to DNA damage (33) and to the 
oxidizing capacity of smoke solutions (135). However, the high reactivity 
of hydroxyl radicals suggests they could be effectively scavenged by more 
abundant ACT components before reaching critical sites on a, PI. The data 
would be consistent with reactive oxygen species (ROS) generated site- 
specifically on ^ P l  (where scavengers have poor access) being responsible 
for some of the damage to a,PI in ACT (225). Hydroxyl radical scavengers 
have been demonstrated to react with hydroxyl radicals generated in ACT 
(22). Thus, damage to a,PI by radicals derived from scavengers could be 
another explanation for the lack of protection by mannitol and benzoate. 
However, previous studies have shown that alkyl, alkoxyl and peroxyl 
radicals do not affect the EIC of o,PI (219). The lack of protection by 
mannitol and serine (Tables 11 & 12) imply that homogeneously generated 
hypervalent metal species, such as ferryl, are not involved in damage to 
o,PI by ACT (226,227).
Ascorbate and the thiols could exert their protective action in ACT 
by several mechanisms. The direct reaction of thiols with hydrogen 
peroxide has been determined to be slow (205,228), but over the extended 
incubation times used in the studies with ACT direct reaction could be of
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some importance. Since ascorbate and the thiols are effective reducing 
agents they could reduce adventitious transition metal ions in ACT which 
could then participate in the Fenton reaction, to decom pose hydrogen 
peroxide to more reactive species, such as hydroxyl radicals. Even though 
the incubation buffer is treated with Chelex*-100, adventitious transition 
metal ions are likely to be present (229); the  cigarettes will also supply 
transition metals (6). The incubations were performed under air, therefore 
oxygen is likely to compete very effectively with hydrogen peroxide for 
reduced transition metals. As discussed below, ascorbate and the thiols 
could autoxidize in ACT and deplete oxygen in the closed vial incubations; 
the decomposition of hydrogen peroxide by Fenton reactions would 
therefore be more pronounced during the later stages of the incubations.
The oxygen content of the closed vials is sufficient to support 
autoxidation of ascorbate and thiols. Autoxidation will not only deplete 
oxygen in the vials, but will decrease the concentration of reducing groups 
and generate ROS (230). Clearly (Table 12) under closed vial incubations 
the protective abilities of ascorbate and thiols at 10 mM predominate over 
any contribution their autoxidation may make to the loss of a, PI activity by 
generation of ROS, or their potential to regenerate autoxidizable ACT 
components such as hydroquinones (223). The protective action of 
ascorbate and the thiols at 1 mM is negligible (Table 12), probably due to a 
combination of exhaustion of reducing ability through autoxidation and
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poorer competition with a,PI for oxidants. The minimal protective ability of 
GSSG (Table 12) demonstrates that the sulfhydryl group of GSH is 
responsible for the protective action of this compound.
In air-purged incubations the protective abilities of the reducing 
agents are noticeably different (Table 13), the order of a,PI protection is: 
Met ~  thiourea > GSH > ascorbate — Cys > DTT, This order of 
protection can be explained by the differing autoxidation properties of the 
various compounds. Thiourea and Met likely autoxidize the slowest, Cys 
autoxidizes faster than GSH, and DTT autoxidizes faster than both of the 
monothiols (231). Under continual air-purging, the  differing degrees of 
autoxidation of the protective species will generate differing quantities of 
ROS and at the same time deplete differing amounts of protective groups.
Thiourea, like Met, protects at both 1 and 10 mM, which is probably 
due to slower autoxidation and the demonstrated ability of thiourea to react 
directly with hydrogen peroxide (232-234). The hydroxyl radical 
scavenging and metal complexing properties of all of the reducing species 
probably contributes minimally to their protective ability in ACT, since 
benzoate, mannitol and high concentrations of potent metal complexing 
agents fail to provide more than 50%  protection (Tables 12 and 14). Even 
though thiols, ascorbate and thiourea have been reported to react with 
superoxide (235-237), such reactions are probably unimportant for 
protection of ^ P l  against damage by ACT.
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Data to be presented later indicate that MetSO formation in a, PI 
exposed to ACT is the probable explanation for the EIC loss. Thiols, at 
high concentrations, long (>  15 h) incubation times and often high 
temperature (>  50 *C), are able to reduce MetSO to Met (238). Since long 
incubation times are used in the ACT studies and the reducing agent:o,Pi 
molar ratio is about 4000:1 (10 mM reducing species), the protective 
effect of thiols could partly be due to "repair" of oxidized cr,PI. Such a 
repair action may also be feasible for ascorbate and free methionine (239).
3 .1 .3 .4  The effect  of  chelators on the ACT m ediated damage to o,P/. 
Metals in ACT could participate in damage to o,Pl in several ways. More 
reactive oxidants (such as hydroxyl radicals or hypervalent transition metal 
species) could be generated from reactions of transition metals with 
hydrogen peroxide (226). The a, PI could be damaged site-specifically by 
the interaction of hydrogen peroxide with transition metal-o^PI complexes 
(225). Also, transition metals are likely to be catalysts of polyphenol 
autoxidation and subsequent generation of hydrogen peroxide (230). In 
ACT all of these factors may be involved to differing extents in the actions 
of the various chelators tested. As noted earlier, adventitious transition 
metals are likely to be present in the incubation buffer, and the cigarettes 
may provide a maximum of 0.5 gM iron and copper in ACT (6,229). 
Chelators only exert effects in ACT at high concentrations, this could be 
due partly to competition between added chelators and chelators in ACT
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[e.g. polyphenols). However, other factors such as limiting concentrations
of transition metal ions and reducing species could also be important.
Previous studies demonstrate that 30 mM EDTA added to ACT 
results In an approximately 16*fold increase in the hydroxyl radical/spin-trap 
adduct signal (22). This increase in hydroxyl radical flux w as proposed to 
occur via a metal catalyzed Haber-Weiss reaction (equations 18 and 21 
below), although quinol/semiquinone driven Fenton reactions could also be 
involved (equations 17, 18, 21 and 24, below} (22,33,34).
M
j. Hj0 2— > Mn+ + H0« + HO'
QH_ + Mn+ >  Q*" + H+ +
I Z ± Q  + Mlr“1,+Mn +
(18)
(2 1 )
(17)
(24)
In the absence of EDTA, hydroxyl radical spin adduct signals in ACT 
are low (22). Thus, transition metal-ACT component complexes cause 
minimal hydrogen peroxide decomposition, or EDTA serves to transfer 
hydroxyl radical generation to locations accessible to the spin-trap. Unlike 
EDTA, 30 mM DTPA abolishes hydroxyl radical spin-adduct signals in ACT 
(22). Thus it has been concluded that metal catalyzed Haber-Weiss or 
quinol/semiquinone driven Fenton reactions are not supported by DTPA- 
bound metals in ACT (22). Protection by DTPA (Table 14) could therefore
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occur by inhibition of transition metal-catalyzed polyphenol autoxidation 
and/or the removal of protein-bound metals from sensitive sites on a,PI. In 
addition to  the  mechanisms noted for DTPA, EDTA probably protects a.,PI 
by degrading hydrogen peroxide to more reactive and less selective ROS 
via an EDTA-metal ion complex. The failure of benzoate to improve the 
protective effect of EDTA suggests that hydroxyl radical generation by 
EDTA-metal complexes does not compromise the protective effects of 
EDTA.
It is unlikely that DTPA or EDTA protect by the direct scavenging of 
OjPI-damaging species. Firstly, additives that would be considered more 
effective scavengers of a, Pl-damaging agents (Lys, His, Trp and Pro for 
example) do not protect o,PI from ACT damage (Table 11). Secondly, 
EGTA and HIMDA, which are structurally similar to DTPA and EDTA but 
less effective chelators of transition metals, show poorer protective ability 
(Table 14).
Ferric ions added to ACT show some protection of a,PI (Table 14), 
probably via the degradation of hydrogen peroxide by an iron-ACT 
component complex. The addition of ferric chloride to cigarette smoke 
solutions has been shown to increase the decomposition of hydrogen 
peroxide to more reactive species (25). The fact that benzoate does not 
enhance protection by ferric ions (Table 14) suggests that the protective 
effects of ferric ions are not compromised by an increased flux of free
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hydroxyl radicals. Other factors, such as binding of ferric ions to or,PI, may 
negate some of the protective potential of the ferric ions.
In contrast to EDTA and DTPA, Desferal* did not protect a, PI (Table 
14), which could indicate that ferric ions are not involved in ACT damage 
to a,PI. However, the effects of Desferal* in ACT would be expected to be 
similar to the effects of DTPA, i.e. the inhibition of both the decomposition 
and generation of hydrogen peroxide. Some studies have shown that 0 .5 
mM Desferal* inhibits the generation of ROS in cigarette smoke solutions 
(25). Any protective actions of Desferal* could be compromised by 
reaction with superoxide in ACT to produce a protein damaging nitroxide 
radical (240,241).
Copper has received particular attention with regard to site-specific 
damage to proteins including a,PI (242-245), and could feasibly be involved 
in or, PI damage by ACT. Both DTPA and EDTA are reasonable cupric ion 
chelators [log stability constants for Cu (II) of 21 .4  and 18.8 respectively 
(246) ], thus their effects could also be explained on the basis of copper 
complexation. The most protective of all the chelators studied is DDC 
(Table 14), which because of its structural similarity to thiourea is likely to 
protect mostly by sacrificial oxidation rather than copper complexation. 
Bathocuproine disulfonate, a chelator of cuprous ions, does not protect a, PI 
(Table 14).
106
Since EDTA, DTPA, Desferal* and histidine were all unable to protect 
a, PI from damage by ACT, then site-specific damage to critical residues in 
a, PI by metal catalyzed ROS generation seem s unlikely or plays a minor 
role (225,247-249). Although, if multiple mechanisms operate in ACT to 
damage a , PI, all of which are dependent on hydrogen peroxide, then 
elimination of any one mechanism will not prevent the loss of EIC.
2x2 Modelling Aqueous Cigarette Tar Extract-Mediated Damage to o TPI.
The overall aim of the studies in this section w as to model ACT- 
mediated EIC loss of a, PI using simpler systems. Much of the data 
reported so far implies that the damage to o,PI by ACT contains a 
substantial oxidative component, dependent on hydrogen peroxide. The 
studies in this section are designed to determine whether or not hydrogen 
peroxide per se  could be responsible for most of the EIC loss of or, PI 
exposed to ACT.
Studies on ACT/hydrogen peroxide combinations were performed to 
detect any synergism between ACT components and hydrogen peroxide. 
Incubations of a, PI with ACT under low oxygen tensions assessed  the 
importance of oxygen in the ACT damaging mechanism.
The above experiments depended on reasonable estimates of the 
amount of hydrogen peroxide generated by ACT. Some previous studies 
were helpful in estimating hydrogen peroxide formation in ACT (23).
107
However, there are some difficulties in using the data from the earlier study 
(23) and experiments reported in this section of the dissertation were 
designed to address these difficulties. Since a preliminary study indicated 
that MetSO w as the product of ACT-methionine interaction, experiments 
were geared toward detection and quantitation of MetSO. The quantitative 
data could be used to estimate the oxidative capacity of ACT toward Met.
As will be noted in section 3 .2 .2  the hydrogen peroxide exposures 
show  responses to protective species similar to those observed for the ACT 
exposures. Hydrogen peroxide exposures adequately account for MetSO 
formation in fl^PI exposed to ACT (section 4.1), but do not reproduce the 
ACT-damage to o,PI in terms of changes in electrophoretic mobility (section 
4.2). Studies using catechol/hydroquinone may provide a better model for 
ACT damage to a,PI, since the quinols provide oxidants and are reducing 
species, a situation more akin to ACT.
3.2 .1  Experimental.
3 .2 .1 .1  Estimation o f the oxidizing capacity o f ACT: Analyses o f
methionine, methionine sulfoxide and valine exposed to ACT. Incubations 
of 500 pL total volume were performed under the standard conditions in 1 
mL Eppendorf vials. Control incubations of 15.6 mM Val + 8 .4  mM 
MetSO or 16.4 mM Val + 11 . 8  mM Met were done in incubation buffer 
only. After 24 h incubation the samples were frozen and lyophilized. 
Following Iyophili2 ation the residues were dissolved in 1 mL of 0 .4  N boric
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acid, pH 10.2 and diluted 1/100 with the same buffer. The samples were 
then filtered through individual filter syringes (LID/X filter syringes, 0 .45  
//m, nylon- 6 6  filter; Xydex Corp., Bedford, MA) and the filtrate transferred 
to HPLC vials.
The HPLC analyses were performed on a Hewlett-Packard, HP 1090 
liquid chromatograph equipped with a diode array detector, ternary solvent 
delivery system, variable-volume auto-injector, auto-sampler, 
thermostatically controlled column compartment and a 200 x 2.1 mm, 5 p, 
Hypersil OOS microbore amino acid analysis column (Hewlett-Packard, Palo 
Alto, CA). Samples were subjected to an on-line pre-column derivatization 
procedure, using an injection program, with 25 mM mercaptopropionic acid 
and 25 mM o-phthaldialdehyde prior to injection (250I. Injections of 26 pL 
were made, containing 5 pL of sample solution mixed with 0 .4  N borate, 
pH 10.2 and the derivatizing agents. Analyses were performed at 35 °C 
and the chromophore was detected at 338 nm. The mobile phase was 
composed of a binary solvent system: solvent A, 20 mM sodium acetate, 
pH 7.2, containing 0.1 mM EDTA, 0 .5%  v/v tetrahydrofuran and 0 .015%  
v/v triethylamine; solvent B, 80%  v/v acetonitrile/20% v/v 0.1 M sodium 
acetate. Solvent A was decreased non-linearly from 98%  to 0%  over 15 
min, at a flow rate of 0 .44  mL/min (250). Calibration curves were 
constructed using 5, 50 and 100 pM standards containing a mixture of 
valine, methionine and MetSO. The chromatograms were processed using
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software supplied with the HPLC system.
3 .2 .1 .2  The effect o f hydrogen peroxide a t concentrations relevant to 
those produced in ACT on the activity o f a,Pi. The effect of hydrogen 
peroxide alone on the EIC of a^PI was determined by incubating 1.3 mM 
hydrogen peroxide with 125 p Q / m L  o,PI under the standard conditions. 
Hydrogen peroxide w as added as three aliquots, 5, 5 and 10//L  of an -  
20 mM stock at 0, 4  and 6  h, to give concentrations of 0 .33 , 0 .66  and 1.3 
mM hydrogen peroxide respectively. The final incubation volume was 315 
pL. This repetitive addition protocol was adopted to avoid exposing a,PI to 
hydrogen peroxide in one step.
A time course of the loss of EIC of a,PI exposed to 1.3 mM 
hydrogen peroxide by the multiple addition protocol w as constructed by 
simply determining the EIC at selected time points. The effects of some of 
the additives that protected in ACT were also tested in this cleaner 
hydrogen peroxide system, In all cases incubations were under the 
standard conditions, using hydrogen peroxide at 1.3 mM added according 
to the protocol described in the above paragraph.
3 .2 .1 .3  The effect of  ACT/hydrogen peroxide combinations, and ACT 
under iow  oxygen tension, on E/C foss o f a,Pi. Studies on the interaction 
of hydrogen peroxide with ACT components involved exposures of 125 
P Q / m L  a,PI to ACT for 24 h under normal or low oxygen tensions in the 
presence of 0 .9  mM hydrogen peroxide. Hydrogen peroxide w as added as
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three aliquots, 5, 5 and 1 0 //L of an 18.5 mM stock a t 0, 4  and 6  h, to 
give concentrations of 0 .23 , 0 .46  and 0 .89  mM hydrogen peroxide 
respectively. The final incubation volume w as 415 //L. Also, 4  hr 
incubations of or, PI with hydrogen peroxide and ACT were performed; 
hydrogen peroxide w as added at the start of the experiment to give a 
concentration of 0 .4  mM in a 400  /sL incubation volume. In all cases 
where hydrogen peroxide solutions were added over time, control 
incubations received equal volumes of deionized water. Incubations under 
low oxygen tensions were continuously purged with argon, whereas 
incubations under normal oxygen tensions were continuously purged with 
air (see section 3.1.2.2).
3 .2 .1 .4  Catechol and hydroquinone as a m odel for the effects of  ACT on 
a,PI. Alpha,PI at 125 //g/ml w as exposed to 230 fjM catechol and 
230 ^M hydroquinone, the exposures also contained 0.1 |/M Fe(ill) and 
0 .3  #/M Cu(ll). The catechol and hydroquinone stocks were prepared fresh 
at the start of every experiment. The incubations were done under the 
standard conditions and the EIC determined after 24 h. The time course of 
the loss of EIC of a,PI exposed to catechol/hydroquinone was simply 
determined by assessing EIC at selected time points. In some cases 
additives were used to assess protective effects toward o,Pt exposed to 
the catechol/hydroquinone mixture.
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3.2,2 Results,
3 .2 .2 .1  Estimation o f the oxidizing capacity of ACT: Analyses of 
methionine, methionine sulfoxide and valine exposed to ACT. The data 
from this experiment are presented in Table 22. When Met is incubated 
with ACT under the standard conditions, MetSO, and not methionine 
sulfone, is produced. The ACT contains no species that are detectable by 
the amino acid analysis procedure, as determined when only ACT is 
injected into the HPLC. The production of MetSO can be used to estimate 
the oxidizing capacity of ACT toward Met. After 24 h, 1.28 jt/moles of Met 
are oxidized to MetSO/ml ACT (Table 22).
The negligible change in Vat and MetSO concentrations after 
exposure to ACT (Table 22) suggests that ACT has little affect on the 
integrity of the or-amino or carboxyl groups. Since only about 60%  of the 
decrease in Met content after exposure to ACT is accounted for by the 
increase in MetSO (Table 22), a portion of Met is depleted in ACT by 
uncharacterized pathways. If ACT were able to reduce MetSO to 
methionine, this could lead to an underestimation of the oxidizing capacity 
of ACT; however, incubation of MetSO with ACT for 24 h does not result 
in the measurable formation of Met (Table 22).
3 .2 .2 .2  The effect o f  hydrogen peroxide a/one, and in combination with 
ACT, on the activity o f a,Pi. Under low oxygen tensions, a,PI activity is 
unaffected by ACT (Table 23). Co-incubation of ACT and 0 .9  mM hydrogen
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Table 2 2 . A nalysis o f M et, MetSO and Val exp osed  to ACT.
Incubation"
% change in 
concentration* l/mol MetSO
Val Met MetSO"
formed
Val + Met + 
ACT
- 1.5 
± 0 .3
- 18.9 ± + 11.1 
1.4 ± 0 .2
0 .6 4  ± 0 .0 2 -
Val + MetSO + 
ACT
+ 3.1 
± 0 . 1
N.D.* - 0 .6  ± 
0 .3
a - See Experimental.
b - After 24 h, relative to amino acids incubated in buffer only:
+ , indicates increase; indicates decrease. Mean ± s.d. of three ACT 
preparations, 
c - As a percentage of initial Met concentration, 
d - Mean ± s.d. for 3 ACT preparations, 
e - Not detected.
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Tabla 23. The effect of ACT and hydrogen peroxide alone and in 
combination under normal and low oxygen tensions on the EIC of a,PI.
Exposure [0 2] Time, h* % EICfc
ACT Normal 24 15 ± 4 “
ACT Low- 24 96 ± 4"
ACT Normal 4 70 ± 3
ACT Low 4 1 0 2  ± 2
ACT + 0 .4  mM H20 2 Normal 4 55 ±  4
ACT + 0 .4  mM H20 2 Low 4 87 ± 3
ACT + 0 .9  mM H20 2 Normal 24 0
ACT + 0 .9  mM H20 2 Low 24 35 ± 2
0 .4  mM H20 2 Normal 4 94  ± 3*
0 .9  mM H20 2 Normal 24 33 ± 6 *
1.2 mM H20 2 Normal 24 42 ± 4 1
1.3 mM H20 2 Normal 24 33 ± 14"
a - Incubation time.
b - Unless indicated, data are means ± s.d. of three separate ACT
preparations, 
c - Five separate ACT preparations, 
d - Flushed continually with argon; see Experimental, 
e - Six ACT preparations, 
f - Five ACT preparations, 
g - Seven ACT preparations.
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peroxide leads to abolition of EIC after 24 h under normal oxygen tensions, 
but not under low oxygen tensions (Table 23). Some data were obtained at 
4  h incubation to study further the synergistic interactions between ACT and 
hydrogen peroxide. Under normal oxygen tensions, ACT 
enhances the damaging effects of 0 .4  mM hydrogen peroxide (Table 23). 
However, under low oxygen tensions ACT only minimally increases the 
damage to a,PI by 0 .4  mM hydrogen peroxide (Table 23).
Data for the effects of additives on the activity of a,PI exposed to 1.3 
mM hydrogen peroxide are presented in Table 24. The percent protection 
values were calculated according to equations 4  and 5 in section 3.1, with 
"hydrogen peroxide" substituted for "ACT" in these equations. Figure 6  
show s a time course of the loss of EIC of a,PI exposed to 1.3 mM hydrogen 
peroxide added by the multiple addition protocol.
3 .2 .2 .3  Catechol and hydroquinone as a model for the effects o f  ACT on 
a,PL The concentrations of catechol, hydroquinone, Fe(lll) and Cu(ll) used 
for the exposures of or, PI were calculated according to the levels of these 
species found in 1R1 cigarettes:
Fe: 0 .042  //g/cig.
Cu: 0 .1 9  //g/cig.
Catechol: 110-300 /yg/cig.
Hydroquinone: 100-300 //g/cig. (12).
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Table 24 . The e ffect o f varioua com pounds on the activity o f o,PI exp osed
to 1 .3  mM hydrogen peroxide.
Additive* % Protection*
Ascorbate 93 ± 3
Thiourea 97 ± 2
Methionine 92 ± 3
DDC 94 ± 1
DTPA - 2 ± 3
50 mM Benzoate - 2 ± 3
EDTA 7 ± 3
EDTA + 50 mM Benzoate 10 ± 1
5 mg/mL BSA - 10 ± 10
GSH 97 ± 3
Ala - 10 ± 2
a - All at 10 mM unless indicated otherwise, 
b - Mean ± av.dev. for two independent runs.
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Figure 6 . Time course of the EIC loss of 125^/g/ml o^PI exposed to 1.3 mM 
hydrogen peroxide. The hydrogen peroxide was added at three times (see 
Experimental).
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The concentrations used in the exposures assum e complete 
extraction of all four species (250 //g/cig. for each of the 
dihydroxybenzenes) into ACT, thus the exposures represent upper levels. In 
hindsight, the addition of the transition metals was perhaps pointless, as 
phosphate is the most abundant complexing agent in the incubations 
(100 mM).
AlphajPI exposed to catechol/hydroquinone [plus Fe(lll)/Cu(ll)] 
retained 47 ± 6 % EIC (mean ± s.d.; 9 separate incubations). Omission of 
the Fe(lll) and Cu(ll) resulted in the retention of a further 10 ± 1 % EIC 
(mean ± av.dev.; 2 separate incubations). The data concerning the effects 
of various species tested for protective ability are presented in Table 25.
Figure 7 shows a time course of the loss of EIC of a, PI exposed to 
the catechol/hydroquinone system. The rate of loss of EIC is comparable to 
that of the hydrogen peroxide and ACT exposures.
3-2,3 Discussion.
3 .2 .3 .1  Estimation o f the oxidizing capacity o f ACT. If hydrogen peroxide 
is the primary oxidant of Met in ACT, then MetSO formation can be used to 
estimate the hydrogen peroxide content of ACT. Peroxides oxidize sulfides 
with a 1:1 stoichiometry (251), thus data on Met oxidation shown in Table 
22 would indicate the formation of 0 .64  ± 0 .02  //moles of hydrogen 
peroxide in the ACT incubations {i.e. 1.28 ± 0 .0 4  mM hydrogen peroxide).
A previous study has quantitated hydrogen peroxide production in ACT (23),
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Table 2 5 . The e ffec t o f various com pounds on the activity o f fffPI exposed
to 2 3 0  f /M catech ol, 2 3 0  //M hydroquinone*.
Exposure % Protection*
10 mM Thiourea 54  ± 1
10 mM Methionine 96 ± 4
10 mM DTP A - 5 ± 5
10 mM GSH 94  ± 2
5 mg/ml BSA 92 ± 4
50 mM Benzoate - 16 ± 1
10 mM Methionine sulfoxide 59 ± 1
10 mM Methionine sulfone 65 ± 1
10 mM Ala 69 ± 3
a - Plus 0.1 fiM Fe(lll) and 0.3 fjM Cu(ll). 
b - Mean ± av.dev. for 2 runs.
119
100  *
80
l u  60
40
20
0 5 10 15 20 25
TIME,  H
Figure 7. Time course of the loss of EIC of 125 //g/ml crtPI exposed to 
230 /sM catechol/230 /sM hydroquinone.
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but depending on how the data are interpreted, different quantities of 
hydrogen peroxide can be calculated to have formed in 24 h. If we assum e 
there is no turnover of hydrogen peroxide in ACT then after 24 h, 0 .84  ± 
0.21 mM hydrogen peroxide would be calculated to be present. On the 
other hand, if the hydrogen peroxide is continually generated and destroyed, 
then a minimum of 2 .86  ± 0 .24  mM hydrogen peroxide would be estimated 
to form in ACT.
It w as noted in section 3.2.2.1 that only about 60% of the Met was 
detected as MetSO. The remaining 40%  is unaccounted for and at least 
two possibilities for the fate of this 40%  can be ruled out: Met w as not 
oxidized to methionine sulfone as this would have been detected by HPLC; 
modification of the a-amino or carboxyl groups is unlikely, since Val 
underwent no overall change. Underestimation of the amount of hydrogen 
peroxide in ACT would have little impact on the studies of damage to a, PI, 
since higher levels of hydrogen peroxide would incur even greater damage 
than that observed in the studies presented in section 3 .2 .2 .2 . Reduction of 
MetSO to Met by ACT is undetectable, thus ruling out one possible reason 
for underestimation.
Gross overestimation of the hydrogen peroxide content of ACT by the 
Met oxidation method is more troublesome. A major contributor to 
overestimation would be a lack of specificity of Met oxidation. Most of the 
oxidizing capability of cigarette smoke solutions is ultimately attributable to
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hydrogen peroxide (25). Hydroxyl radical is an obvious candidate as a Met 
oxidant since this has been suggested to contribute to the oxidizing capacity 
of cigarette smoke extracts, and hydroxyl radical can oxidize Met to the 
sulfoxide (135,252). Since the data of Nakayama ef at. (23) indicate 0 .84  
± 0 . 2 1  mM as a lower level for hydrogen peroxide concentration in ACT, 
the value of 1.28 mM suggested by the Met oxidation data does not seem 
unreasonable.
3 .2 .3 .2  Hydrogen peroxide and a fP(. If hydrogen peroxide can act alone in 
ACT to damage o,PI, then a concentration of hydrogen peroxide equal to 
that formed in ACT over 24 h should depress a,PI activity to a similar extent 
to that seen for ACT. The data (section 3.2.2.2) suggest hydrogen 
peroxide could account for most of the damage to a, PI caused by ACT. The 
time course (Fig. 6 ) shows that the rate of EIC loss is comparable with ACT- 
mediated EIC loss. Earlier (section 2.1.3) it w as suggested that damaging 
species could accumulate in aged ACT and the damaging reaction could be 
slow. The oxidant quantitation data and the slowness of EIC loss upon 
exposure to hydrogen peroxide supports the idea of the buildup of a slowly 
damaging species. Although it seem s reasonable that hydrogen peroxide 
could directly damage o,PI in ACT, the response of a,PI to hydrogen 
peroxide is variable, causing about 70-80%  loss in EIC. Hydrogen peroxide 
could account for most of the damage to a,PI and its damaging effects may 
be enhanced by interaction with other ACT components.
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Some synergism is observed between the damaging actions of 
hydrogen peroxide and ACT. The apparent synergism between 0 .9  mM 
hydrogen peroxide and ACT is likely due to the additive damaging effect of 
the exogenous (i.e. added) and endogenous (i.e. from autoxidation of ACT 
components) hydrogen peroxide. Under argon, the loss of EIC due to the 
ACT/0.9 mM hydrogen peroxide mixture is attributable to the exogenous 
hydrogen peroxide alone. The damaging effect of the ACT/0.4 mM 
hydrogen peroxide mixture cannot be explained by the combined action of 
exogenous and endogenous hydrogen peroxide, since 0 .4  mM hydrogen 
peroxide alone has no effect on the EIC. The incubation of t^PI with 
ACT/0.4 mM hydrogen peroxide under argon results in a 13% loss of EIC 
Note that the loss of EIC is 15% greater when t^PI is incubated with 
ACT/0.4 mM hydrogen peroxide under air as compared to a,PI incubated 
under air with ACT alone (Table 23). Thus hydrogen peroxide can synergize 
with an unidentified component(s) in ACT to cause enhanced damage to 
o, PI. These data support an earlier suggestion that cigarette smoke could 
enhance the damaging ability of hydrogen peroxide produced from 
inflammatory cells in smokers' lungs (135).
The complete preservation of the EIC of cr,PI incubated with ACT 
under argon confirms the previously assumed dependence on oxygen of ACT 
damage to o,PI. It is reasonable to conclude that an oxidative mechanism(s) 
alone accounts for the loss of EIC of ACT-exposed a,PI.
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The data in Table 23 allow one other point to be addressed, i.e. is 
there any difference between the rate of EIC loss when o,PI is exposed to 
ACT in open as opposed to closed incubation vessels? The answer is no; 
compare data for 4  and 24 h air-purged ACT exposures (Table 23) and the 
time course (Fig 1).
Several of the species tested for protective ability in ACT were also 
tested in the hydrogen peroxide exposures. All of the reducing species 
protect completely, probably for the same reasons noted in section 3 .1 .3 .3  
for ACT. The protection by DDC supports the earlier comment that it can 
act by scavenging oxidants. If the action of DDC w as to remove metals 
bound to a,PI then EDTA and DTPA would be expected to exert similar 
protection against hydrogen peroxide damage. Since BSA does not protect 
or, PI exposed to hydrogen peroxide, this suggests the  protective role of BSA 
in ACT is more than simply by scavenging oxidants. Both EDTA and DTPA 
do not protect against hydrogen peroxide damage to a, PI. Transition metals 
play a negligible role in the hydrogen peroxide-mediated damage to a, PI.
Also, the absence of reducing species implies that Fe(lll)-EDTA, for example, 
cannot participate in a radical driven Fenton reaction. Since Ala does not 
protect a, PI against hydrogen peroxide damage, the protective action of the 
o-amino group toward o,PI in gas phase extract exposures (130) is not due 
to sacrificial oxidation by hydrogen peroxide.
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Despite this information it is still not possible to sta te  categorically 
that hydrogen peroxide alone causes the EIC loss of a,PI exposed to ACT, 
since hydrogen peroxide could still react with one or more ACT components 
to generate the ultimate damaging species. Such an idea must account for 
the slowness of the EIC loss in ACT, e.g. com ponents in ACT that interact 
with hydrogen peroxide could be limiting to the production of damaging 
species, or the ultimate damaging species could dam age cr,PI as slowly as 
hydrogen peroxide.
The majority of the ACT incubations were performed in closed vials. 
Since the damaging mechanism is dependent on oxygen, it seem s prudent to 
assess  the oxygen content of the incubation vials. The 500 gL incubation 
vials contained 300  gL of incubate and a 200 gL headspace.
Air is 21%  Oa, and the density of 0 2 = 1.31 mg/ml at 25 °C.
Vol. 0 2 in headspace = (21/1001.200 gL = 42 gL.
Weight 42 gL 0 2 = 1.31 gg/gi x 42 gL = 5.5 x 10® g.
MW 0 2 = 32, therefore 5.5 x 10® g = 1.72 x 10" mole 0 2.
Molarity of 0 2 in headspace = [(1.72 x 10 ® x 10001/0.2]
= 8 . 6  mM
[0 2] in water at 25 °C = 0 .26  mM
Therefore incubation vials contain (8 . 6  + 0.26) -  9 mM 0 2.
The calculation indicates that there is sufficient oxygen present to account 
for the estimated hydrogen peroxide to be produced in ACT.
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As w as noted earlier (section 3.1.3.1), much evidence suggests that 
polyphenols are the major source of hydrogen peroxide in cigarette smoke 
solutions. The amount of autoxidizable species estimated to be present in 
ACT will place a limit on the quantity of hydrogen peroxide that could 
possibly be generated. Phenols are found at about 0 .6  mg/cig (6 ) in the 
particulate phase and if we assume complete extraction and an average 
molecular weight of 1 1 0  (dihydroxybenzenes) then we would estimate ca.
1.1 mM of these species in a 500 pi incubation of ACT {i.e., as used for the 
Met oxidation studies). Since it is highly unlikely that the extraction is 
100%  efficient, 1.1 mM is an upper estimate. The MetSO formation studies 
estimated at least 1.3 mM "oxidant" in ACT. Therefore there are probably 
additional autoxidizable species in ACT and oxidized quinones may be 
reduced after autoxidation; e.g.,  addition of water to  p-benzoquinone 
generates further autoxidizable species (223).
3 .2 .3 .3  Catechol/hydroquinone and a fPl. Initially it w as thought that 
exposures of c r ,  PI to catechol plus hydroquinone would model more closely 
the effects of ACT on or, PI than hydrogen peroxide alone. The degree and 
rate of EIC loss of or,PI exposed to catechol/hydroquinone is comparable with 
that for the hydrogen peroxide exposures (sections 3 .2 .2 .2  & 3). However, 
like the hydrogen peroxide exposures the changes in electrophoretic mobility 
of catechol/hydroquinone-exposed o,PI did not mimic those of ACT-exposed 
a,PI (section 4.2.2). Also, the effects of agents tested for protective ability
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were noticeably different from their effects in ACT. Overall, the 
catechol/hydroquinone system was a poorer model than the hydrogen 
peroxide exposures.
It is likely that catechol/hydroquinone damages a,PI by a combination 
of lysyl group modification and oxidation (of Met). Since MetSO, methionine 
sulfone and Ala protect a,PI by ca. 60%, they all share a common protective 
feature. The o-amino group is the probable protective functional group, 
most likely by nucleophiiic attack on quinones. There is precedent in the 
literature for the addition of amines to quinones, and for loss of EIC of a, PI 
after modification of lysyl residues (216,217,222). The higher protective 
ability of Met and GSH would be due to both sacrificial oxidation and 
reaction with quinones. Also, BSA is very protective and this is likely to be 
due to effective competition with a,PI for oxidants and quinones. The lack 
of protection by DTPA implies that metal-catalyzed Haber-Weiss reactions 
are not involved in the damage to a, PI. This conclusion is supported to 
some extent by the failure of benzoate to protect. As with the ACT studies 
other explanations for the failure of benzoate to protect o r ,  PI can be invoked, 
such as site-specific generation of ROS or homogeneous production of ferryi. 
Ferric-DTPA complexes, for example, can be reduced by catechols, and 
presumably p-hydroxyphenols, and their semiquinones [the slower reaction 
of o-semiquinones with oxygen implies these would be more effective
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reducing species for Fe(lll) (253) ) thus DTPA is not expected to abolish 
polyphenol autoxidation although it may inhibit it (229,253-255).
Although the catechol/hydroquinone system is a poor model with 
regard to ACT, the apparent protective effect of amine groups is reminiscent 
of gas phase cigarette smoke (GPE) studies (130). Damage to a, PI by gas 
phase cigarette smoke extract is inhibited by unprotonated amine groups and 
catalase; hydrogen peroxide was proposed as a damaging species (130).
Loss of EIC by o,PI exposed to GPE could also involve derivatization of lysyl 
residues by formaldehyde/hydrogen cyanide (2 1 2 ,2 2 0 ), carbonyls (2 2 1 ) and, 
on the basis of the studies presented above, quinones (222). One notable 
difference between the damage due to GPE and catechol/hydroquinone is 
that the former is not inhibited by the thioether functionality of Met, only the 
o-amino group (130).
CHAPTER 4
STRUCTURAL DAMAGE TO a,PI BY AQUEOUS CIGARETTE TAR EXTRACT.
4 J .  Amino Acid Analysis of q ,PI Exposed to Aqueous Cigarette Tar Extract 
and to Hvdrooen Peroxide.
The cyanogen bromide cleavage technique (256) was used to study 
Met oxidation in o ^ l .  This analytical procedure does not interfere with the 
detection of other amino acids, apart from glycine, which under the HPLC 
conditions employed co-elutes with homoserine generated from the 
cyanogen bromide-methionine reaction. This amino acid analysis procedure 
w as adopted on the basis of the data already presented, indicating Met 
oxidation by ACT, and the established fact of EIC loss associated with 
Met368 oxidation in ^ P l  (see Chapter 1). Tryptophan, proline and cysteine 
were not determined in these analyses.
4, h 1 Experimental.
Alpha,PI at 125 //g/ml was exposed to ACT (3.1.1.1) or 1.2 mM 
hydrogen peroxide (3.2.1.2). The EIC loss w as determined prior to amino 
acid analysis.
The samples were filtered through a 10 ,000 nominal molecular 
weight limit, low-protein binding, cellulosic membrane filter. The residue 
w as then washed with 2 x 500 //I of water, and the washed residue
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suspended in 210  fj\ 70%  v/v formic acid. The samples in formic acid were 
transferred to glass screw-cap vials and 100 //I of a 123 mM cyanogen 
bromide solution in 70%  v/v formic acid w as added. Since cyanogen 
bromide is volatile and highly toxic it was always handled in a fume hood 
with extreme caution. The samples were left to incubate with cyanogen 
bromide for 24 h at room temperature. After the 24 h incubation, the 
samples were transferred to hydrolysis tubes and the  formic acid removed 
under vacuum. To the dried samples 100 fj\ of 6 N hydrochloric acid 
(containing 1 . 8  mg/ml DTT) was added to each hydrolysis tube, the tubes 
were placed in a hydrolysis vial. Hydrolysis w as done at 110 °C, in vacuo 
for 24 h. After hydrolysis, the hydrochloric acid w as removed under 
vacuum and the hydrolysate was suspended with agitation in 300 //I of 0.4N 
borate buffer, pH 10.2. The samples were then filtered through individual 
filter syringes (0.45 */m, nylon) and the filtrate transferred to HPLC vials.
The amino acid analyses by HPLC were performed as described in 
3 .2 .1 .1 . Calibration curves were constructed using standards made by 
dilutions of a commercially prepared 2.5 mM stock (Pierce Chemical Co., 
Rockford, IL). The chromatograms were processed using software supplied 
with the HP 1090 liquid chromatograph system.
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4 .1 ,2  Results.
The amino acid analysis data for the individual residues are presented 
as percentages of the total amino acid content (Table 26). The "Literature" 
values were derived by considering data from references 121 and 257-259: 
the total number of residues in o,PI was calculated (excluding Cys, Trp and 
Pro) to be 375; the percentage for Gly + homoserine w as derived using the 
sum of the number of Met (which will produce homoserine after reaction 
with cyanogen bromide) and Gly residues.
The residue percentages for the native a,PI samples agree well with 
the literature values. The supplier of the a,PI indicated that the product 
contains < 5 %  impurities, but this has negligible impact on the amino acid 
analyses. The only explicable difference in the amino acid content of flr,PI 
exposed to the two treatm ents is the formation of MetSO. The Leu content 
of hydrogen peroxide-exposed a, PI was decreased compared to native c^PI. 
The decrease in Leu is an inexplicable result since hydrogen peroxide would 
not be expected to modify this or other aliphatic residues. Statistical 
analysis of the data seems redundant, since the differences between 
treatm ents were obvious, however a t-test conducted on all of the  data 
revealed no new insights on the data, apart from a significant difference (P 
> 0.05) in the MetSO contents of the hydrogen peroxide- vs ACT-exposed 
a,Pi.
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Table 26. Comparison of amino acid residua contents of native o ^ l,  or,PI 
exposed to ACT and 0,1*1 exposed to hydrogen peroxide.
Amino
acid
residue
Percentage of total residues*
Lit. Native* Ha0 2* ACT4
Asx 11.70  (0.77) 13.05 (1.52) 13.82 (0.1) 12.80  (1.50)
Glx 13.60 (0.8) 14.30  (1.43) 15.07 (1.09) 14.32 (1.86)
Ser 5.60  (0.53) 5.14 (0.64) 4 .86  (0.74) 5 .19  (0.46)
His 3 .20 (-) 3 .32 (0.22) 3.28  (0.36) 3 .08  (0.42)
Gly + 
hSer*
8 . 0 0  (0 .8 ) 9 .13  (1.22) 8.08  (1.54) 8 .54  (1.33)
Thr 7.47 (0.54) 8.08 (1.29) 8 .80  (0.30) 8 .34  (1.15)
Ala 6 .4 0  (0,27) 7 .04  (0,77) 6.97  (1.12) 6 .83  (0.95)
Arg 1.87 (0.27) 2 .00  (0.65) 1.66 (0.24) 2 .24  (0.81)
Tyr 1.60 (-) 1.26 (0.37) 1.31 (0.33) 1.53 (0.00)
Val 6 .40  (0.53) 7.38 (0.57) 7.28 (0.24) 7.52 (0.45)
MetSO - 0 . 0 0  (0 .0 0 ) 0 .45  (0.10) 0 .82  (0.24)
He 5.07  (0.54) 4 .90  (0.22) 4 .73  (0.10) 4 .92  (0.24)
Phe 7 .20  (0.53) 7.04 (0.20) 6.89  (0.37) 7 .08  (0.57)
Leu 12.27 (1.07) 11.94 (0.30) 11.12 (0.40) 11.59 (0.48)
Lys 9 .60  (1.07) 9.03 (0.84) 8 .16  (0.76) 8 .43  (1.31)
a - Mean (s.d.). b - Sample size = 4. 
c - 1.2 mM hydrogen peroxide; sample size = 5. 
d - Sample size = 7. e - hSer; homoserine.
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4 , 1J2 Discussion.
The detection of MetSO in both the hydrogen peroxide- and ACT- 
exposed a,PI is significant given the demonstrated loss of EIC of c r ,  PI when 
Met3*8 is oxidized (55,72,91). Although a number of earlier reports support 
the idea that Met in o r , PI is oxidized after exposure to aqueous cigarette 
smoke solutions in vitro, Met oxidation has not been directly demonstrated 
(124,130 ,138 ,142). The detection of MetSO in hydrogen peroxide-exposed 
o,PI is not unexpected; MetSO formation is the primary reason for the loss 
of EIC of a,PI after hydrogen peroxide exposure (260). The population of 
damaged a,PI resulting from treatment with hydrogen peroxide or ACT is 
possibly a mixture of o r , PI molecules containing none, one or more than one 
MetSO. Since the hydrogen peroxide and ACT exposures result in EIC loss, 
then Met3*8 is the residue that is oxidized predominantly. Treatment of a,PI 
with oxidants such as Chloramine-T, IM-chlorosuccinimide and 
myeloperoxidase/hydrogen peroxide/chloride results in the oxidation one to 
two Met, namely Met3*8 and Met361, both of which are exposed to the 
solvent on the reactive site loop in a^PI (120,121,261). Thus, the 
demonstrated susceptibility of Met361 to oxidation makes it reasonable that 
this residue could also be oxidized in a,PI exposed to ACT, and to hydrogen 
peroxide. However, it is believed that oxidation of Met3*1 does not affect 
EIC (138,262). Other Met residues in a,PI, not accessible to the solvent, 
could be oxidized after ACT or hydrogen peroxide exposure, since some
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studies have indicated that solvent accessibility is not necessarily a 
determinant of the susceptibility of Met residues to oxidation (263).
Although the above discussion has focused on the oxidation of Met, 
modification of Lys and Tyr residues in a,PI are known to diminish EIC, 
whereas Cys or Arg modification affect other proteinase inhibitory functions 
of cr,Pt (217 ,218 ,257 ,264 ,265). There is no evidence from the amino acid 
analyses that either Lys or Tyr are affected by hydrogen peroxide or ACT 
exposure. Despite the apparent absence of changes to amino acids other 
than Met, this does not imply that other residues are unaltered by exposure 
of a,PI to hydrogen peroxide or ACT. For example, the sample treatment 
and harsh protein hydrolysis conditions could reverse some amino acid 
residue modifications, this is probably more applicable to the ACT-exposed 
a,PI. Some amino acid residue modifications may be irreversible, but could 
be beyond the limit of detection of the analytical procedure.
Hydrogen peroxide at neutral or slightly alkaline pH is capable of 
oxidizing thioether, sulfhydryl, imidazole, phenol and indole groups (266). 
Studies with hydrogen peroxide (Table 26) show no apparent modification of 
groups other than thioethers, and if other groups are modified, previously 
published studies imply that they are of little importance with regard to loss 
of EIC (260).
Addressing the more complex situation with ACT, we would perhaps 
expect more than just modification of Met to occur. However, the amino
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acid analysis reflect no other substantial, irreversible amino acid residue 
modifications (Table 26). The amino acid protection studies (section 
3.1 .2 .1) would imply that modification, irreversible or otherwise, of amine 
(e-amino of Lys), aromatic (Phe), indole (Trp), guanidino (Arg) and imidazole 
(His) groups, if they occur in ACT*exposed a,PI, are of no consequence with 
respect to EIC loss. This conclusion necessarily assum es that the free amino 
acids have similar reactivities to the residues in their various chemical 
environments in the protein. Interaction of a protein bound metal with 
hydrogen peroxide can produce highly localized damage affecting very few 
susceptible residues, however such damage can be devastating to protein 
function (248); such relatively small changes in amino acid composition may 
go undetected in the analyses presented in Table 26. Several types of 
residue may undergo oxidation by this so-called "metal catalyzed oxidation'’ 
pathway; a contribution by this pathway to ACT damage to a,PI cannot be 
discounted.
In summary, the amino acid analysis results, in conjunction with the 
protection data from the free amino acid studies, suggest that oxidation of 
Met is the primary cause of EIC loss of a, PI exposed to ACT. Direct 
oxidation of Met by hydrogen peroxide is a probable mechanism for this 
modification, although metal catalyzed oxidation of Met could also be 
involved. Other amino acid residue modifications cannot be disregarded, but 
it is likely that such modifications are not related to the loss of EIC.
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4^2 Analysis of Native and Damaged a, PI bv Denaturing and Non- 
Denaturina pQlvacrvlamide Gel Electrophoresis.
4 .2 .1  Experimental.
Samples of native o,PI, o,PI exposed to ACT (2.1.1.3), hydrogen 
peroxide (3.2.1.21, or catechol/hydroquinone (3.2.1.4), with and without 
additives were subjected to electrophoresis under both the denaturing and 
non-denaturing conditions. The EIC values were determined prior to the 
electrophoresis. The gels were cast in an HSI (Hoefer Scientific Instruments, 
San Francisco, CA) gel casting unit and run using an HSI SE 250 vertical 
slab gel electrophoresis unit. The various components of the gel systems 
were as follows, electrophoresis grade reagents were used throughout. The 
denaturing gel had the following composition; 0 .1%  w/v SDS, 11% w/v 
acrylamide, 0 .29%  w/v bis-acrylamide, 11 % w/v sucrose and 0 .37  M Tris*- 
HCI, pH 8 .8 . The stacking gel had the following composition; 0 .1%  w/v 
SDS, 3 .8%  w/v acrylamide, 0 .1%  w/v bis-acrylamide, 0 .13  M Tris*-HCI, pH 
6 .8 . The reservoir buffer contained 0 .1%  w/v SDS, 0 .19  M glycine and
0.025 M Tris*-HCI. For denaturing electrophoresis, 100 of incubate was 
mixed with 50 //I of incubation buffer and 150 ywl of sample buffer. The 
samples were heated at 95 °C for 5 min. Blanks consisting of sample buffer 
and incubation buffer only were also prepared in the sam e way, as were 
molecular weight markers appropriately diluted from a commercial 
concentrate (SDS-PAGE molecular weight standards, low range; Bio-Rad
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Laboratories, Richmond, CA). The final composition of the sample for 
electrophoresis consisted of; 42 j/g/ml a, PI, 2% w/v SDS, 0.1 % v/v 
glycerol, 0 .05%  v/v mercaptoethanol, 0 .001%  w/v bromophenol blue and
0 .0 6  M Tris*-HCI, pH 6 .8 . The samples were cooled and 5 j/L aliquots were 
applied to wells in the stacking gel. The gels were run in the anodal 
direction, a t a stable temperature (ca, 23 °C), using 7.5 mA/gel for the 
stacking gel and 15 mA/gel for the separating gel.
The non-denaturing gels had the following composition; 8 % w/v 
acrylamide, 0 .21%  w/v bis-acrylamide, 5.5%  w/v sucrose and 0 .37  M Tris*- 
HCI, pH 8 .8 . The other components of the electrophoresis system  were the 
same as noted for the denaturing gels, except that SDS was excluded. The 
sample buffer contained neither SDS nor mercaptoethanol.
After electrophoresis, the gels were immediately fixed and stained for 
1 h with a solution of 50% v/v methanol, 10% v/v acetic acid and 0.1 % 
w/v Coomassie Brilliant Blue R-250. After 1 h, gels were destained 
overnight or until the background w as sufficiently clear, with 5% v/v 
methanol, 7% v/v acetic acid. In most cases the gels were stained further 
using a silver staining kit (Sigma Chemical Co.I to intensify the bands. After 
conditioning in 2%  v/v glycerol the gels were dried using an HSI gel drier, 
Then photographed.
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4 ,2 ,2  Results.
The gels are displayed in Figures 8  to 13, the anode is a t the bottom 
of the gel in all cases, where two lanes on the same gel apparently have the 
sam e material in them, these  were from separate incubations; only one 
incubation of native or, PI was used per experiment. Unless indicated 
otherwise, the catechol/hydroquinone incubations contained Cu(ll) and 
Fe(lll).
On the SDS-PAGE gels, the native o,PI band migrated to a position 
consistent with its molecular weight <52 kDa) {Fig 8-10). There was no 
detectable change in band position for the ACT or hydrogen peroxide 
treatments, but the catechol/hydroquinone exposed a,PI showed band 
broadening with some movement to slightly lower molecular weights 
{Fig 9). Methionine and DTPA had no impact on the ACT exposed o,PI 
bands (Fig 10), whereas methionine but not DTPA caused the 
catechol/hydroquinone band to "tighten" into a native o,PI band {Fig 10). In 
the absence of Cu{ll) and Fe(lll) the catechol/hydroquinone exposure showed 
no difference in band structure compared to the exposures in the presence 
of Cu{ll) and Fe(lll) (Fig 10).
The three types of exposure showed different responses on the non 
denaturing gels. The native o,PI consistently gave tw o bands, one more 
intense and anionic than the other (Fig 1 1 - 1 3 ) .  The identity of the less 
anionic band is unknown; t^PI exists in two major isoforms in normal human
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Figure 8 . SDS-PAGE of native a,PI, a,PI exposed to ACT end a.,PI exposed 
to 1.3 mM hydrogen peroxide. Gel fanes are as follows: lane 1, MW 
standards; lane 2, native a,PI; lane 3, t^PI exposed to ACT; lane 4, a,PI 
exposed to 1.3 mM hydrogen peroxide; lane 5, a,PI exposed to ACT; lane 6, 
native a,PI; lane 7, o,PI exposed to 1.3 mM hydrogen peroxide; lane 8, MW 
standards.
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Figure 9. SDS-PAGE of o tPI exposed to ACT and cr,PI exposed to 
catechol/hydroquinone. Gef lanes are as follows: lane 1, MW standards; 
lane 2, o,PI exposed to ACT; lane 3, a,PI exposed to catechol/hydroquinone; 
lane 4, native cr,PI; lane 5, OtPI exposed to ACT; lane 6, a ,P I exposed to 
catechol/hydroquinone; lane 7, native c^PI; lane 3, MW standard.
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Figure 10. SDS-PAGE of o,PI exposed to ACT and crtPI exposed to 
catechol/hydroquinone in the presence of DTPA and methionine. Gel lanes 
are as follows: lane 1, MW standard: lane 2, or,PI exposed to 
catechol/hydroquinone [no Cu(ll) or Fe{ll)J; lane 3, c^PI exposed to 
catechol/hydroquinone plus 10 mM DTPA; lane 4, a,P! exposed to 
catechol/hydroquinone plus 10 mM methionine; lane 5, native o^PI; lane 6, 
a, PI exposed to ACT plus 10 mM DTPA; lane 7, ^ P l  exposed to ACT plus 
10 mM methionine; lane 8, MW standard.
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Figure 11. Non-denaturing PAGE of native Gr-,PI, ar,PI exposed to ACT and 
or,PI exposed to 1.3 mM hydrogen peroxide. Cel lanes are as follows: lane 
1, native o,PI; lane 2, a^Pt exposed to ACT; lane 3. native a,PI; lane 4, c^PI 
exposed to 1.3 mM hydrogen peroxide; lane 5, native o.,PI; lane 6, OtPI 
exposed to ACT; lane 7, native or,PI; lane 8, o,PI exposed to 1.3 mM 
hydrogen peroxide.
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Figure 12. Non-denaturing PAGE of ar,PI exposed to ACT plus catalase and 
or,PI exposed to ACT under argon. Gel lanes are as follows: lane 1, a,PI 
exposed to ACT plus catalase; lane 2, a, PI exposed to ACT; lane 3, a,Pt 
exposed to ACT under argon; lane 4, native o,PI; lane 5, catalase; lane 6, 
OtPI exposed to ACT plus catalase; lane 7, a^Pt exposed to ACT under 
argon; lane 8. (^Pl exposed to ACT.
Figure 13. Non-denaturing PAGE of c^PI exposed to catechol/hydroquinone 
plus 10 mM alanine, and a, PI exposed to ACT plus 10 mM amino acids.
Gel lanes are as follows: fane 7, a,PI exposed to catechol/hydroquinone; 
lane 2. a,PI exposed to catechol/hydroquinone plus 10 mM Ala; lane 3, 
native o,PI; lane 4, a,PI exposed to ACT; lane 5, o,PI exposed to ACT plus 
10 mM Lys; lane 6, a,PI exposed to ACT plus 10 mM Arg; lane 7, o,PI 
exposed to ACT plus 10 mM Met; lane 8, o,PI exposed to ACT plus 
10 mM Ala.
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serum with pi values differing by 0 .2  units. It seems unlikely that the two 
bands represent two isoforms since the difference in pi is probably too small 
to have an effect on mobility in these gels. The t^PI w as used as received 
from the supplier, thus this minor band could represent the < 5 %  
contamination. Since the SDS-PAGE gels gave only one band for a,PI it is 
evident that the contaminant has a similar molecular weight to o,PI. The 
gels were all stained with silver stain, so the less anionic band is likely 
present at very low amounts relative to the more anionic band. The results 
and discussion presented in the following sections pertain to the more 
intense anionic band.
Exposure of <r,PI to ACT results in smearing of the native band in the 
anodal direction, indicating an increase of overall negative charge on the 
protein (Fig 11-13). The hydrogen peroxide exposures have no effect on the 
a,PI band position and intensity. The catechol/hydroquinone exposures also 
cause smearing of the o,PI band toward the anode (Fig 13). Under argon, or 
in the presence of catalase, the native a,PI band still smears toward the 
anode; catalase is more cationic relative to c^PI and does not contain any 
contaminants that co-migrate with the a,PI (Fig 12). The effect of 
catechol/hydroquinone on the electrophoretic behavior of the o,PI is mildly 
reversed by 10 mM Ata (Fig 13). The effect of ACT on the electrophoretic 
behavior of the o,P( is mildly reversed by 10 mM Lys, Ala, Arg or Met (Fig 
13).
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4 ,2 ,3  Discussion.
The evidence so far indicates that ACT damages a,PI by an oxidative 
mechanism, primarily oxidation of Met. In an attem pt to reproduce the 
effects of ACT on a, PI the hydrogen peroxide and catechol/hydroquinone 
models were used. The additional data from electrophoresis has 
substantiated the inadequacy of the two models. The hydrogen peroxide 
exposures account reasonably well for the MetSO formation in ACT-exposed 
o,PI, but do not reproduce the non-denaturing gel changes of ACT-exposed 
c^PI. On the other hand, the catechol/hydroquinone system  does not show 
the same changes as ACT-exposed a,PI on the SDS gels, but does more 
closely resemble the changes on the non-denaturing gels.
The increase in the anionic nature of the o,PI exposed to ACT 
indicates that ACT components mask or eliminate positive charge on the 
a, PI. An increase in the anionic mobility on non-denaturing gels has been 
noted for o,PI exposed in vitro to whole smoke extracts (134,136). The 
a, PI exposed to hydrogen peroxide does not show increased movement 
toward the anode. Thus, oxidation of Met is not a suitable explanation for 
the increase in anionic mobility. Since the incubation of a,PI with ACT plus 
catalase or ACT under argon does not affect the band smearing, then 
oxidative processes are probably not a involved in this increased anionic 
movement on non-denaturing gels. Also, the increase in anionic behavior of 
a, PI after exposure to ACT is not related to EIC loss because under argon
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ACT causes the  same electrophoretic changes even though the EIC is 
completely preserved (section 3.2.2 .2). One cannot discount, however, that 
the mechanisms for the band smearing under argon are different for those 
under air. The ability of 10 mM Lys, Ala or Arg to partly restore native or, PI 
band character to the ACT-exposed cr^PI, yet the failure of these three amino 
acids at 10 mM to protect against loss of EIC (section 3 .1 .2 .1), supports the 
idea that the band smearing of a, PI caused by ACT is unrelated to loss of 
OfPI activity. The band smearing in non-denaturing gels is possibly due to 
either non-covalent interaction of ACT components with positive charges on 
c^PI (Lys and Arg side chains) or reversible covalent modification of Lys 
and/or Arg residues. Covalent modification of 20%  of the Lys residues in 
o,PI (ca. 7 residues) results in a 20%  loss of EIC, w hereas modification of 
Arg residues does not affect EIC (217). Evidently ACT com ponents do not 
affect Lys residues critical to EIC, if such residues are modified by ACT 
components.
Alpha-1-PI exposed to catechol/hydroquinone show s increased 
movement toward the anode on non-denaturing gels. In the presence of 
10 mM Ala the catechol/hydroquinone-exposed o,PI slightly more like native 
a,PI. It was suggested in section 3 .2 .3 .3  that catechol/hydroquinone may 
damage o,PI by a combination of oxidation of Met and covalent modification 
of Lys. The increase in anionic behavior of the catechol/hydroquinone- 
exposed a,PI is consistent with modification of positively charged residues.
147
The protective effect of Ala is probably due to sacrificial modification of the 
o-amino group which would minimize the electrophoretic changes. Purely 
oxidative changes would not cause the altered mobility of 
catechol/hydroquinone-exposed a,PI, since the hydrogen peroxide alone had 
no effect on o,PI mobility.
On the SDS gels there is no indication of significant aggregation or 
fragmentation of a,PI exposed to ACT or hydrogen peroxide. The exposure 
of a,PI to catechol/hydroquinone does shift the native a,PI band to a slightly 
lower molecular weight range which is indicative of fragmentation of the 
a,PI. If the SDS gel changes for the catechol/hydroquinone-exposed a,PI are 
indicate fragmentation then redox active metals could play a role in the 
generation of species responsible for polypeptide chain scission. Hydroxyl 
radicals or hypervalent transition metal species generated on, or close to, the 
protein could cause such scission and the damage would also be dependent 
on hydrogen peroxide. The addition of 10 mM DTPA to the 
catechol/hydroquinone incubations does not affect the apparent 
fragmentation (neither does the exclusion of the Fe(lll) and Cu(ll) additions), 
suggesting the following: metals are not involved in the damage; DTPA 
cannot compete for metals with ff,PI (at a DTPAio^PI molar ratio of 4000:1, 
this is unlikely); even with DTPA present metals can still participate in 
reactions such as the radical driven Fenton reaction. Adventitious metal ions 
can be sufficient to cause protein fragmentation in the presence of hydrogen
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peroxide (249), so, even if the Cu(ll) and Fe(lll) are not added to the 
incubations this may have little effect on the damage to o,PI. The 
dihydroxybenzenes are a source of reducing ability for metal ions to produce 
more reactive species from hydrogen peroxide that could fragment a, PI. 
Hydroxyl radicals are produced in solutions containing catechols, DTPA and 
ferric ions (254). Thus, inclusion of DTPA in the or,PI incubations with 
catechol/hydroquinone does not eliminate the possibility of ROS generation.
Protein fragmentation mediated by ROS, especially those produced 
site-specifically, usually results in specific fragmentation patterns, and 
seldom produces complete dissolution of the protein 
(215 ,243 ,248 ,249 ,267). The shift in the mean band position for the 
catechol/hydroquinone-exposed c^PI is consistent with loss of fragments of 
a few  kDa. The changes seen for catechol/hydroquinone-exposed o^PI on 
SDS gels are not related to increased anionic mobility on non-denaturing gels 
since the ACT-exposed o,PI is also more anionic and yet show s no change in 
mobility on the SDS gels.
Unlike DTPA, 10 mM Met protects o,PI from catechol/hydroquinone 
damage and restores the mobility of c^PI on SDS gels to that of the  native 
protein. The protection by methionine is most likely due to scavenging of 
oxidants, thus preventing the generation of species that could fragment a, PI. 
Covalent attachm ent of quinones to o,PI via amino groups, and the
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subsequent reduction of the quinones, allows for localized autoxidation of 
the protein-attached quinols with the generation of ROS.
4 ,2 .4  Summary and future studies.
Aqueous cigarette tar extract, causes a slow steady loss of the EIC of 
OtPI at 37 °C, pH 7.4, to give at least a 60%  loss of EIC in 24 h. The ACT 
retains its ability to damage flr,PI for many hours. Changes in pH and 
adsorption of o,PI onto particulates are discounted as reasons for the loss of 
EIC.
The damage to o,PI by ACT is dependent on hydrogen peroxide, but 
superoxide plays no direct role in the damaging mechanism. Hydroxyl 
radicals or hypervalent metal species generated in the homogeneous phase 
are not o^l-dam aging species in ACT, compatible with their high reactivity 
and unselectivity. The production of reactive oxygen species site- 
specifically on o,PI cannot be discounted.
The loss of EIC of c^PI is due to oxidative damage. Non-oxidative 
modification does occur when or, PI is exposed to ACT, resulting in a more 
anionic protein, but such modification does not cause loss of EIC. The non- 
oxidative changes are not reflected in an altered content of amino acid 
residues in o,PI, suggesting such changes are reversible or unrelated to 
amino acid modification. Additionally, no major fragmentation of o,PI 
exposed to ACT is detected. Hydrogen peroxide could account for the major 
portion of damage to ACT-exposed o,PI, by direct oxidation Met358.
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Oxidation of Met368 is sufficient to cause a substantial loss of EIC. In 
support of this, free Met but not MetSO protects against damage to or, PI by 
ACT, and ACT-exposed or,PI contains noticeable quantities of MetSO. At 
concentrations relevant to those produced in ACT, hydrogen peroxide 
causes appreciable formation of MetSO in flr,PI and the rate of EIC loss is 
comparable to that seen for ACT exposure.
Hydrogen peroxide appears to be a reasonable model for the oxidative 
changes in a, PI, but does not reproduce the non-oxidative modifications. 
Exposure of o,PI to catechol/hydroquinone was used to try to mimic the EIC 
loss, non-oxidative changes and the effects of protective agents in the ACT 
exposures. Catechol/hydroquinone causes a similar rate of EIC loss to ACT 
and also increases the anionic mobility a, PI, but otherwise this system bears 
minimal resemblance to ACT. Oamage to ^ P l  by catechol/hydroquinone 
probably occurs by a combination of oxidation of Met and modification of 
Lys.
The protective action of sulfhydryls and ascorbate in ACT varies with 
the incubation conditions, and could be due to various factors, e.g. direct 
reaction with hydrogen peroxide. There are many potential roles for 
transition metals in the mechanism of ACT damage to a, PI, but none of the 
chelators tested protect completely. Protection by the chelators is probably 
related to the inhibition of production, or the degradation of, hydrogen 
peroxide. Removal of protein bound metals from a,PI, to inhibit metal
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catalyzed protein oxidation of Met for example, probably would not affect 
the loss of EIC since hydrogen peroxide could still directly oxidize critical 
methionyl residues.
Several factors need to be taken into account concerning the 
potential for cigarette smoke particulate components to damage o,PI in vivo 
as addressed in the following discussion. Damage to a, PI is thought to be a 
highly localized event. One would not expect homogeneous distribution of 
o,PI, antioxidants or cigarette smoke components in the lung. Thus, the 
chance for direct damage to a, PI by cigarette smoke com ponents is greater 
at sites in the lung where the a,PI and antioxidant concentrations are low 
and the concentration of cigarette smoke components is high. The detection 
of very localized damage difficult because the bronchoalveolar lavage 
techniques currently used do not enable the sampling of lung 
microenvironments.
Lung ELF is endowed with several low molecular weight antioxidants, 
such as glutathione, ascorbate and vitamin E and the variation in the amount 
of some of these antioxidants in smokers' ELF has been measured 
(268-270). Also, the ELF contains macromolecular antioxidants; 
ceruloplasmin, transferrin, catalase and SOD have been detected 
(269,271,272). The various antioxidants in ELF are likely to hinder not only 
any damage to c^PI caused by the direct action of cigarette smoke, but also 
dam age due to inflammatory cell oxidants (273). Hydrogen peroxide can
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diffuse across membranes, and therefore in addition to extracellular 
scavenging, hydrogen peroxide generated extracellularly can be degraded 
intracellularly (137,274-276),
Cigarette smoking imposes a chronic oxidative burden on the lung. In 
areas where there is ongoing oxidative insult to the lung lining fluid, and 
thus perhaps poorer antioxidant protection, cigarette smoke com ponents 
would be expected to have a more direct impact on a,PI. Smokers almost 
continually introduce cigarette smoke material into their lungs to replace that 
which is slowly removed by the impaired clearance mechanisms. Under 
normal circumstances, o^PI, HNE and elastin are present simultaneously, and 
the presence of the elastin ensures that even relatively mild decreases in ct,PI 
activity can markedly increase the degradation of elastin by HNE (72,131).
The studies in this dissertation arose from previous studies in vitro by 
the Pryor research group on gas phase smoke interaction with a,PI and the 
interaction of ACT with DNA. Further examination of ACT damage to a,PI 
would probably serve only to fine tune the study. Additional studies of 
cigarette smoke component/o,PI interaction in vitro are probably of more use 
in conjunction with in vivo studies. Human studies are beyond the 
immediate scope of the Pryor group, but some more useful human studies 
await the development of substantially improved lung fluid sampling 
techniques. Two further studies related to cigarette smoke/a, PI interaction 
that could be done with experimental animals are presented below.
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One of the most outstanding problems to date concerning the direct 
interaction in vivo of c r ,  PI with cigarette smoke com ponents is whether it 
actually occurs! Many studies have implied that oxidation of a,PI occurs in 
vivo after acute and chronic cigarette smoke inhalation (see Chapter 1). 
However, the relative contribution to such supposed oxidation from cigarette 
smoke vs inflammatory cells is unknown. Those studies that show  no 
apparent oxidation of o,PI in smokers' lungs frequently do not discount 
oxidation for a variety of reasons including poor sampling of lung 
microenvironments or reluctance to discount oxidation. Unless cigarette 
smoke oxidants cause a unique and reproducible pattern of Met oxidation 
then searching for oxidized o,PI is a poor way to assess  its direct interaction 
of cigarette smoke components. One could search for evidence of some 
unique protein modifications caused by cigarette smoke such as 
cyanomethylation quinone addition to Lys side chains, in vitro studies are 
required to detect if authentic quinones or those in smoke can react with 
amino groups in a,PI.
Another avenue of in vivo research is related to determining the 
macromolecular antioxidant status of lung ELF after cigarette smoke 
inhalation. Ideally, this would be done after both acute and chronic smoke 
exposures using a suitable animal model. Whereas studies of low molecular 
weight antioxidants in ELF are ongoing in other laboratories, the 
macromolecular antioxidant status is less well studied (268,269). Part of
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the reason for this poorer study of macromolecular antioxidants in ELF is 
tha t their presence has only recently been appreciated (271,277,278). The 
ELF provides the initial antioxidant defense for the lung and so the ability of 
this fluid to diminish oxidant levels obviously places less of a burden on the 
underlying cell layer as well as protecting important components of the ELF. 
Since the macromolecular antioxidants are proteins their function could be 
impaired by the action of cigarette smoke and inflammatory cell-derived 
oxidants. This study unfortunately suffers from the same problem of 
microenvironment sampling, but this has not hindered the acquisition of 
useful data on the low molecular weight antioxidants.
Obviously the best preventative measure for cigarette smoke-induced 
disease is not to smoke, but this approach has evidently failed in numerous 
cases. Since cigarette smoking is unlikely to disappear in the near future, 
continued research on the chemistry of cigarette smoke and the pathological 
mechanisms of cigarette smoking-induced disease is justified. Smoking is a 
major public health problem that proves costly both in terms of life and 
healthcare. Research into the basic mechanisms of smoking-induced disease 
should ultimately enable the development of suitable measures to reduce the 
risk to smokers' and non-smokers' health, until such a time as the smoking 
habit is abandoned.
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APPENDICES
APPENDIX A
AlphajPI, or c^PI - Alpha-1-proteinase inhibitor.
ACT - Aqueous cigarette tar extract.
AM - Alveolar macrophage(s).
Av.dev. - Average deviation.
BPTI - Bovine pancreatic trypsin inhibitor.
BSA - Bovine serum albumin.
DDC - Diethyldithiocarbamate.
DGP - Direct gas phase.
DTPA - Diethylenetriamine pentapentaacetic acid.
DTT - Dithiothreitol.
EDTA - Ethylenediamine tetraacetic acid.
EGTA - (Ethylenedioxy)diethylenenitrilo tetraacetic acid. 
EIC - Elastase inhibitory capacity.
ELF - Epithelial lining fluid.
ESR - Electron spin resonance spectroscopy.
GPE - Gas phase extract.
GSH - Glutathione.
GSSG - Oxidized glutathione.
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HIMDA * N-(2-hydroxyethyl)iminodiacetic acid.
HNE - Human neutrophil elastase.
HPLC - High pressure liquid chromatography.
MetSO - Methionine sulfoxide.
NE - Neutrophil elastase.
PMN - Polymorphonuclear leukocyte(s); neutrophil(s). 
PPE - Porcine pancreatic elastase.
ROS - Reactive oxygen species.
SANA - N-succinyl-(L*Ala)3-p-nitroanilide. 
s.d. - Standard deviation.
SOD - Superoxide dismutase.
TPM - Total particulate m atte-.
X/XO - Xanthine/xanthine oxidase.
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